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ABSTRACT OF THE DISSERTATION
Long-Term Hypoxia Alters Ovine Fetal Adrenal eNOS and Cortisol Biosynthesis
by
Elizabeth Anne Newby
Doctor of Philosophy, Graduate Program in Physiology
Loma Linda University, June 2015
Dr. Charles A. Ducsay, Chairperson

Maintaining normal levels of cortisol in response to chronic stress, while retaining
the ability to respond to acute stress, is important for ensuring normal fetal growth and
development. Long-term hypoxia (LTH) causes adaptations in the fetal hypothalamopituitary-adrenal (HPA) axis that maintain basal cortisol levels but enhance production in
response to a secondary stress. Nitric oxide (NO), produced by endothelial nitric oxide
synthase (eNOS) in the adrenal cortex, plays a significant role in regulating cortisol
production in the LTH fetus. The production of NO is regulated by eNOS activity which
can be altered via phosphorylation through key signaling pathways. In examining the
effects of the MEK/ERK1/2, PI3K/Akt, and calcium signaling pathways, we found that
the MEK/ERK1/2 pathway and calcium do not regulate eNOS phosphorylation (peNOS),
but the PI3K/Akt pathway, along with ACTH, regulates peNOS in LTH fetal
adrenocortical cells (FACs); inhibition of the PI3K/Akt pathway resulted in reduced
peNOS and enhanced cortisol production in response to ACTH in LTH FACs. Defining
the regulatory role of these pathways will enhance our understanding of how these
adaptations to LTH impact the fetus.

xiii

CHAPTER ONE
FETAL ENDOCRINE AND METABOLIC ADAPTATIONS TO HYPOXIA

Elizabeth A. Newby,1 Dean A. Myers,2 and Charles A. Ducsay.1

1

2

Center for Perinatal Biology, Loma Linda University, Loma Linda, CA 92350 and
Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences
Center, Oklahoma City, OK 73104.

Running Head: Fetal adaptations to hypoxia
Key Words: fetus, cortisol, adipose, hypoxia

Correspondence:

Charles A. Ducsay, Ph.D.
Center for Perinatal Biology
Loma Linda University, School of Medicine
Loma Linda, CA 92350
cducsay@llu.edu
(909)-558-4325, FAX (909)-558-4029

Supported by National Institutes of Health Grants PO1HD31226, R01HD51951

Part of the work presented in this chapter has been submitted for publication to the
American Journal of Physiology - Endocrinology and Metabolism.

1

Abstract
In utero, hypoxia is a significant, yet common, stress that perturbs homeostasis
and can occur due to preeclampsia, preterm labor, maternal smoking, heart or lung
disease, obesity, and high altitude. The fetus has the extraordinary capacity to respond to
stress during development, This is mediated, in part, by the hypothalamic-pituitaryadrenal (HPA) axis and, more recently explored, changes in perirenal adipose tissue
(PAT) in response to hypoxia. Obvious ethical considerations limit studies of the human
fetus and fetal studies in the rodent model are limited due to size considerations and
major differences in developmental landmarks. The sheep is a common model that has
been used extensively to study the effects of both acute and chronic hypoxia on fetal
development. In response to high-altitude induced, moderate long-term hypoxia (LTH),
both the HPA axis and PAT adapt to preserve normal fetal growth and development,
while allowing for responses to acute stress. LTH upregulates the HPA axis at the level of
the hypothalamus and anterior pituitary yet maintains the normal ontogenic pattern of
cortisol production during late gestation. Two mechanisms converge at the adrenal cortex
that facilitate this divergent effect on fetal HPA function. In the PAT, LTH increases
leptin production, which suppresses adrenocortical gene expression, while nitric oxide
aids in maintaining acute cortisol production within the adrenal cortex. Although these
adaptations appear beneficial during fetal development, they may become deleterious
postnatally and into adulthood. This review will discuss some of the endocrine and
metabolic adaptive changes that take place in response to hypoxia.

2

Introduction
Mammalian fetuses, and in particular fetuses from long gestational length
pregnancies such as humans (primates) and ruminants, have the ability to respond to
and/or adapt to stress during gestation to survive the potentially harsh intrauterine
environment and continue to term. Post-birth, both the hypothalamic-pituitary-adrenal
(HPA) axis, via cortisol, and the adrenomedullary/sympathetic nervous system (SNS), via
catecholamines, serve as homeostatic regulators in response to acute and chronic stress.
In larger mammalian fetuses, these systems exhibit maturation in late gestation and serve
similar roles, providing the fetus with the means to respond to intrauterine stressors.
While these responses to hypoxic stress may often be beneficial acutely, they have the
potential to be deleterious, especially under sustained periods of hypoxic stress.
The influence of hypoxia during fetal development is of particular importance due
to its potential to induce or “program” alterations in endocrinology and metabolism long
after birth. It has been recognized for over two decades that an “adverse intrauterine
environment” could lead to offspring predisposed to a variety of related disorders
including cardiovascular, metabolic and obesity as adults. This so-called programming,
also referred to as the “fetal origins of adult disease hypothesis”, describes how an
“adverse intrauterine environment” can trigger adaptive or maladaptive changes in the
developing fetus to overcome the hostile conditions and survive (9, 11, 12, 157). Through
epigenetic imprinting, these changes can lead to susceptibility of the fetus to acquire
these cardiovascular and metabolic pathologies. Although the original hypothesis was
largely derived from observations of offspring from malnourished or undernourished
pregnancies, later studies have expanded on the impact of a variety of so-called intra-
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uterine stressors. This has been reviewed in more detail by Godfrey (67) and Calkins
(23).
Fetal hypoxia is a common stressor that occurs during pregnancy as the result of a
variety of situations including maternal under or malnutrition, preeclampsia, preterm
labor, smoking, heart or lung disease, obesity, and exposure to high altitude (13, 35, 46,
73, 94, 142, 160). Therefore, due to its prevalence, hypoxia likely plays a key role on the
impact of an adverse intrauterine environment on the developing fetus. The impact of
hypoxia on the fetus is dependent on a wide range of variables including gestational age,
severity and duration of hypoxia, as well as confounders such as acidemia and
hypercapnia.
When considering changes in response to hypoxic stress, the HPA axis is key due
to its role in growth and maturation of the fetus. The HPA axis, through regulation of
glucocorticoid biosynthesis, dictates differentiation and maturation of key organ systems
including lung, liver, kidney, and regulation of metabolism including lipolysis,
glycogenolysis, and protein catabolism (28, 116, 128). Acutely, activation of the HPA
leads to a significant increase in cortisol (2, 16, 17, 83, 90), a glucocorticoid that plays a
critical role in governing metabolism by influencing plasma glucose, lipid, and protein
concentrations, as well as immune regulation, inflammation, and cardiovascular function.
Under chronic stress conditions, cortisol production is associated with hyperglycemia,
immune suppression, excess adipose deposition, bone loss, and hypertension (33, 158,
173). Therefore, the ability of the fetal HPA axis to adapt to limit cortisol production
under conditions of chronic stress is crucial for maintaining normal development during
gestation. The regulation of cortisol must be effectively coordinated to permit the late
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gestation exponential rise in fetal plasma cortisol essential for fetal maturation, while
permitting episodic cortisol production in response to acute stress.
Another key regulatory mediator influenced by hypoxia in the fetus is perirenal
adipose tissue (PAT). In sheep, approximately 80% of fetal adipose tissue deposition
occurs in the perirenal-abdominal region (171). During late gestation, fetal mass expands
and adipose tissue develops and responds to hormonal and nutritional perturbations that
can alter lipid storage and release, as well as induce secretion of leptin (152). Early
changes in adipose function in response to hypoxia may play a role in fetal programming,
due to the influence of leptin and gene expression on metabolic processes and the
possible overlap between leptin and cortisol regulation.
For obvious ethical considerations, there is little data on the effect of hypoxia on
endocrine and metabolic alterations in human fetuses. Additionally, although there are
programming studies of the effects of hypoxia in rodents, due to the small size and
developmental maturity of the fetus, they are not ideal for fetal endocrine and metabolic
studies. Fetal studies have also been conducted in nonhuman primates, but they are
limited due to the tremendous cost and lack of availability of animals. The sheep has
become a major animal model for studying the impact of hypoxia on the developing fetus
due to its relatively long gestational period, similarity of endocrine and physiological
systems, and relative ease of fetal and maternal instrumentation.
Throughout this review, we will highlight key findings in relation to the impact of
hypoxia on endocrine and metabolic responses of the fetus. Although as previously
described, the majority of information has been derived from studies utilizing the ovine
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fetus, wherever possible, we will draw correlates from human and non-human primate
studies.

Acute Hypoxia
As described above, from a clinical perspective, fetal hypoxia can occur as a
result of a wide range of maternal conditions. In an effort to mimic some of these
conditions, multiple models of hypoxia have been developed. Acute hypoxia can be
induced through maternal hypoxia (6, 37), blood flow restriction (182), or umbilical cord
occlusion (UCO) (61, 69, 176), for a duration of a few minutes to several hours. In
response to of acute hypoxia, there is a rapid release of corticotropin releasing hormone
(CRH) and arginine vasopressin (AVP) from the hypothalamus which triggers
adrenocorticotropic hormone (ACTH) secretion from the anterior pituitary followed by
glucocorticoid production in the fetal adrenal cortex proportional to the degree and
duration of hypoxia. This swift response of the HPA to acute stress emphasizes the
critical role glucocorticoids play in homeostasis and limiting the physiological impact of
stress on the fetus.
Several studies conducted in the fetal sheep examined the effects of acute
hypoxemia induced by reduction in maternal oxygen or by reduction of uteroplacental
blood flow by umbilical cord occlusion (UCO). Akagi and Challis showed that moderate
maternal hypoxia (PO2 reduced by 8.4 mmHg) for 1 hour increased fetal plasma AVP
and ACTH in 106-117 days gestation (dG) fetuses (6). In a later gestation fetus (131 dG),
Unno, et al. observed increased fetal plasma ACTH and cortisol concentrations following
a 50% reduction in blood flow by UCO (176). Further, several studies found that acute
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episodes (1-48h) of fetal hypoxemia (induced by maternal hypoxia or UCO) resulted in
increased CRH mRNA in the fetal hypothalamus, proopiomelanocortin (POMC) mRNA
in the fetal pituitary, and increased circulating AVP, ACTH, and cortisol concentrations
in fetal plasma (7, 17, 19, 27, 90, 114, 145, 159, 169). While the response of the HPA
axis to stress is best seen in the late gestation fetus, as the fetal HPA has matured and
become fully responsive (54), changes in fetal plasma cortisol concentrations in response
to acute hypoxemia have been reported in the ovine fetus as early as 120 dG (16).
Together, the results of these studies exemplify the integrated response of the HPA axis
to acute hypoxic stress.
Although the response to an acute hypoxic insult results in upregulation of the
HPA, prolonged elevated cortisol levels lead to fetal growth restriction and, in ruminants,
activation of the parturition cascade and early birth of small fetus (64, 164). To further
examine the effects of hypoxia as a fetal stress, the response of the fetal HPA axis to
repeated hypoxic perturbations or prolonged hypoxia over the course of several days has
been investigated. Unno, et al. found that after repeated UCOs, fetal anterior pituitary
responsiveness was maintained with increased levels of plasma ACTH released after each
UCO, but adrenocortical responsiveness was blunted; despite elevated ACTH, cortisol
levels remained similar to basal levels by the 12th UCO (176). Green, et al. subjected
112-116 dG fetal sheep to repeated UCOs and saw increased plasma ACTH and cortisol
concentrations but this response was attenuated after 4 days (69). These studies show that
while fetal CRH/AVP and ACTH remained elevated in fetal plasma, cortisol returned to
basal levels by the end of the hypoxic insult.
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In its role as a glucocorticoid, cortisol regulates metabolism by influencing
plasma glucose concentrations. Along with cortisol, plasma glucose levels and fetal
growth and development are also regulated by insulin, a hormone secreted from
pancreatic β-cells in response to increased plasma glucose concentrations that stimulates
cellular uptake of glucose (53). Insulin secretion is tightly coupled to plasma glucose
concentration, maintaining a relatively constant insulin-to-glucose ratio (I/G). However
in response to an acute hypoxic challenge, several studies found that the fetus, had
decreased insulin secretion (87, 187) accompanied by increased norepinephrine (NE) and
epinephrine (E) secretion (36) and increased cortisol and corticosterone secretion (86).
Further studies showed that hypoxic stress acts through an α2-adrenergic mechanism to
induce inhibition of insulin secretion (85, 87, 104, 167). The increase in glucocorticoid
elevated plasma glucose and circulating catecholamines prevented hyperinsulinemia, but
together resulted in hyperlactacemia and hypocarbia (107), showing a direct impact on
fetal metabolism. In response to hypoxia, however, gluconeogenesis is initiated, and the
excess lactate generated is used as a substrate for hepatic glucose production (107). This
sympathoadrenal suppression of insulin secretion may act as a mechanism to conserve
glucose and oxygen for essential organs such as the brain and heart (20, 62), but if
sustained could result in reduced birth weight (85).
In the human fetus, Zamudio, et al. found that women living at high altitude
experienced chronic hypoxia that resulted in IUGR, potentially initiated by fetal
hypoglycemia; there was decreased circulating fetal glucose concentrations and
consumption (190). This suggests altered placental metabolism that spares oxygen for
fetal use but limits glucose availability for fetal growth. IUGR as a result of altered
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glucose metabolism has also been reported in a rat model of hypoxia by Lueder, et al.
(111). They observed that maternal exposure to 5 days of 10% ambient oxygen in the
third trimester resulted in similar fetal plasma glucose concentrations between hypoxic
and control but increased relative glucose utilization of hypoxic fetal tissues accompanied
by acidosis, suggesting anaerobic metabolism and increased glycolysis in the hypoxic
fetus.
In response to changes in metabolism, cortisol works to restore homeostasis to
allow for the continued growth and development of the fetus. In the case of recurring
acute hypoxic stress, continuous bursts of cortisol can become detrimental to fetal
development and lead to a growth restricted fetus delivered pre-term. From these results,
the ovine fetus has demonstrated an adaptation in the HPA axis where there is a
dissociation in the response between the hypothalamic-pituitary axis and the
adrenocortical response to brief repeated hypoxic stress or prolonged hypoxia over
several days. While CRH/AVP and ACTH levels remain elevated, cortisol returns to
basal levels to allow for normal growth and development of the fetus.

Chronic Hypoxia
Experimentally, chronic hypoxia (over days to weeks or even months) can be
initiated early or late in gestation and can be induced through placental embolization (21,
58), placental restriction, secondary to nutrient restriction (51), or by high altitude
resulting in moderate continuous hypoxia with normal pregnancy duration and no
accompanying growth restriction (2, 78, 83, 92). Because the HPA axis matures in the
latter third of gestation and increases in responsiveness as the fetus nears term (25, 101,
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102, 141, 147, 150, 156, 177), studies often measure the effects of hypoxia in late
gestation.
Gagnon, et al. examined the effects of fetal placental embolization (30%
reduction in arterial PO2) for 10 days in 122 dG sheep. It resulted in progressive
hypoxemia with reduced fetal plasma ACTH but increased prostaglandin E2 (PGE2) and
maintained cortisol (58, 131). This suggests that PGE2 may be involved in an adaptation
to maintain basal fetal cortisol levels when ACTH is reduced and indicates that additional
factors other than ACTH play a role in regulating cortisol production in the ovine fetus.
To induce hypoxia by placental restriction (PR), Phillips, et al. performed
caruncletomies prior to mating to reduce the number of placentomes formed in ewes.
This resulted in gestational hypoxia, with fetal arterial PO2 reduced by 30%. This highly
successful model by the McMillen group allows for hypoxia throughout the entire course
of gestation. However, the hypoxia is accompanied by nutrient restriction and IUGR. Due
to PR, there was decreased POMC mRNA in the fetal pituitary and higher cortisol levels
compared to control, despite similar levels of plasma ACTH at 140 dG (151). They
hypothesized that the HPA axis adapts to operate at a new set point in the growth
restricted fetus in response to nutrient restriction.
In the high altitude induced long-term hypoxic (LTH) ovine model, ewes are
maintained at 3820 m beginning at approximately day 40 of gestation and continuing
through to near term (139-141 dG, term is ~145, hypoxic fetal PO2 ~18 mmHg, normoxic
~23 mmHg). In this model, the fetus has adapted to hypoxia such that pregnancies are of
normal duration, fetuses are not growth restricted, and there is no accompanying acidosis
(78, 92). Initial studies examining the effects of LTH on the ovine fetus showed that basal
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immunoreactive (IR) ACTH and cortisol concentrations were similar to normoxic control
fetuses (78, 133). However, subsequent studies revealed that LTH stimulated
hypothalamic drive which enhanced expression of POMC and processing to ACTH with
increased concentrations of ACTH1-39 and key POMC precursors (POMC and 22 kDa
ACTH) in plasma (133). Despite higher basal levels of ACTH1-39, cortisol concentrations
were not increased above normoxic controls in near term fetuses.
This dichotomy became even more interesting in response to a superimposed
acute secondary stressor. Surprisingly, in the LTH fetuses in response to hypotension or
UCO, both ACTH and cortisol increased, but the cortisol response was greater compared
to the response in normoxic fetuses (2, 83, 132). Further studies by Myers, et al.
demonstrated reduced expression of ACTH-R, CYP17, and CYP11A1 with no changes in
CYP21 or StAR in the late gestation LTH fetal adrenal cortex compared to normoxic
controls (135), suggesting that a reduced steroidogenic capacity in the LTH fetus may
play a role in the disconnect between basal ACTH and cortisol levels. However,
mechanisms must exist to allow for a heightened cortisol response to acute stress, despite
the lowered expression of these key steroidogenic enzymes. The fetus has developed such
that despite elevated basal plasma ACTH, normal ontogenic maturation of cortisol
production is maintained and the prepartum exponential rise is preserved as well as the
capacity to respond to an acute secondary stress. These adaptations indicate that the
hypothalamic-pituitary portion of the axis responds to hypoxia as a stress by increasing
the synthesis and release of ACTH secretagogues and activating the stress response
However, adaptive responses at the level of the adrenal cortex suppress excess
stimulation under basal conditions.
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As described above, in the LTH fetal adrenal cortex, there is decreased expression
of CYP11A1 and CYP17, two key enzymes mediating cortisol synthesis, as well as
decreased ACTH receptor expression (135). The reduction of these factors would result
in attenuated adrenal responsiveness to ACTH and limited cortisol production. Along
with these changes, however, there is an increase in the spent form of steroidogenic acute
regulator (StAR) protein (30 kDa), indicating increased transport of cholesterol into the
inner mitochondrial membrane for the first step in cortisol biosynthesis. This could
balance the adaptations of elevated basal plasma ACTH1-39 but reduced adrenal
responsiveness to maintain basal levels of plasma cortisol similar to those observed in
normoxic fetuses. In the LTH adrenal cortex, there are no changes in SF-1 and DAX-1
expression, key transcription factors for ACTH-R and CYP11A1 and CYP17. This
suggests that activation of these transcription factors is altered, possibly via
phosphorylation state or increased recruitment of co-repressors (166).
The mechanisms involved in these adaptations have not been fully elucidated,
however nitric oxide (NO) may play a major role in regulating cortisol production
intracellularly in the LTH fetal adrenal cortex. Tsubaki, et al. examined adrenal tissue and
observed increased expression of endothelial nitric oxide synthase (eNOS) in adrenal
tissue that colocalizes with CYP17 in LTH fetuses suggesting NO plays a role in
regulation of adrenal steroidogenesis (174). Monau, et al. also showed that eNOS is the
dominant NOS isoform in the ovine fetal adrenal cortex, and eNOS mRNA and protein
expression is increased in the LTH adrenal primarily in CYP17 expressing cells in the
cortisol producing zona fasciculate (122). Subsequent studies by Monau, et al. showed
that NO reduced ACTH-mediated cortisol production in LTH fetal adrenocortical cells
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(FACs) in vitro, while inhibition of NOS activity increased cortisol production in LTH
cells, with no effect on normoxic cells (123). Also, ACTH reduced eNOS activation via
phosphorylation in LTH FACs (140), and NO-dependent inhibition of ACTH induced
cortisol production in vitro FACs further supports the role of NO in regulating cortisol
production in the LTH fetal adrenal (175). This may be possible by NO competing with
the oxygen binding site of CYP11A1 and CYP17 (75, 174), disrupting the heme-oxygen
complex attack by the enzyme on the steroid substrate. The increased release of NO
under basal conditions would limit cortisol synthesis, while elevated ACTH release and
signaling due to a secondary stress would inhibit NOS activity and remove NO inhibition,
resulting in enhanced cortisol production in the LTH fetus. This provides a mechanism
(NO) for the capability of the LTH fetus to overcome the reduced steroidogenic enzyme
gene expression and mount an enhanced cortisol response to acute stressors. However the
question remains as to what factor(s) is involved in the decreased expression of the key
steroidogenic machinery in response to LTH?

PAT and Leptin
One factor that my play a role is leptin. This 16 kDa protein derived from adipose
tissue is most widely recognized for its role in appetite regulation in the adult (5, 89).
However, leptin has also been clearly demonstrated to regulate adrenal steroid
biosynthesis. In adult bovine adrenocortical cells, leptin suppressed cortisol output in
response to ACTH stimulation and this effect was mediated through a reduction in
CYP17 and CYP11A1 expression (18, 99). Further, leptin is a hypoxia inducible gene
(110). This adipocyte-derived hormone, like in human fetuses (108), circulates in the
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fetal sheep and increases in abundance in perirenal adipocytes as gestation progresses
(188, 189). As in other metabolic tissues, fetal PAT is influenced by maternal conditions
and intrauterine stressors, such as hypoxia.
In sheep approximately 80% of fetal adipose tissue deposition occurs in the
perirenal-abdominal region (152). Fetal PAT differentiation is initiated in mid gestation,
and expands during late gestation with a concomitant increase in hormone receptor
populations (152). Adipose tissue begins to develop and respond to hormonal and
nutritional perturbations in the fetus which in turn affects lipid storage and release.
Importantly, this adipose tissue depot serves as an endocrine organ with the production of
leptin (152). Along with the intracellular regulation of cortisol production by NO in the
fetal adrenal, extracellular regulation of cortisol and the fetal response to hypoxia may be
regulated by leptin.
When infused into the late gestation ovine fetus, leptin attenuated the prepartum
increase in fetal plasma ACTH and cortisol (80, 115, 189). Ducsay, et al. found that
plasma leptin was elevated in the LTH fetus compared to normoxic controls, with PAT
and placenta expressing higher levels of leptin mRNA (48). Also, OB-Ra (the inactive,
short isoform) leptin receptor expression was reduced in the LTH hypothalamus while
OB-Rb (the active, long-form) expression was increased in the adrenal (48), suggesting
the potential for enhanced leptin activity in the fetal adrenal. Thus, leptin appears to be a
hypoxia-inducible gene in the ovine fetus with the capacity to inhibit cortisol biosynthesis
at the adrenocortical level.
Subsequent studies showed that StAR, ACTH-R, CYP11A1, and CYP17
expression were lower in the LTH fetus (47), and that a 96 hour leptin infusion into late
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gestation spontaneously hypoxemic fetal sheep downregulated CYP21 mRNA, and
ACTH-R and StAR mRNA and protein (168), indicating reduced adrenal responsiveness
and a reduced capacity to produce cortisol. A 4-day infusion of a leptin receptor
antagonist restored expression of CYP11A1 and CYP17 in the LTH fetus to levels
similar to normoxic but did not affect fetal plasma ACTH or cortisol (47), demonstrating
that LTH regulation of leptin can influence adrenal steroidogenic enzyme expression.
Although leptin plays a role in regulating the response of the HPA and adipose
tissue to chronic stress, it works alongside cortisol and the adrenal to facilitate the fetal
adaptation to hypoxia. Understanding the role of leptin in the intrauterine environment
and the influence it has on the fetal HPA will help determine the long-term metabolic
consequences of early life events and may include the ability of leptin to influence the
development of obesity and its comorbidities.

Metabolic Gene Expression
Along with the production of leptin, other factors in adipose tissue are affected by
hypoxia and may have a metabolic impact on the fetus. In the fetal sheep, as well as the
human, PAT has classically been considered a brown fat deposit (brown adipose tissue,
BAT). It expresses uncoupling protein 1 (UCP1) (26, 34, 42), which increases proton
conduction of the inner mitochondrial membrane and catalyzes adaptive thermogenesis
(24, 170). This enables the rapid generation of a significant amount of heat, and
expression is most abundant in the newborn (170).
The fetal perirenal adipose depot in the LTH fetus, however, has been
characterized with an unusual brown fat phenotype; there are mixed populations of
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multilocular deposits, typical of white fat, and unilocular fat deposits, more common in
brown fat. Leptin expression is more typical of white fat and it is equally distributed in
unilocular and multilocular adipocytes with UCP1 staining distributed throughout the
PAT. This unique phenotype has been termed “beige” fat; white adipose tissue (WAT,
myf+5 lineage) expressing as BAT (myf-5) (26, 42, 70, 84, 149, 161). Within this tissue,
Myers, et al. showed upregulation of UCP1, deiodinase 2 (DIO2), 11β hydroxysteroid
dehydrogenase 1 (HSD11β1), peroxisome proliferator-activated receptor (PPAR) γ and
PPAR coactivator (PGC) 1α mRNA in the LTH fetal adipose (134). As hallmarks of the
brown fat phenotype, LTH appears to enhance brown fat functionality, and increased
HSD11β1 and DIO2 would allow adipose tissue to increase the BAT phenotype without
systemic increases in cortisol and triiodothyronine (T3) which would deleteriously impact
fetal growth and organ function. Along with upregulated brown fat gene expression,
Myers, et al. found increased mRNA of transcription factors that regulate expression of
NRF2 and mtTFA, genes that govern mitochondrial function (136), further indicating a
BAT phenotype.
The fetal adaptation to LTH in adipose tissue appears to involve increased leptin
production and regulation of basal cortisol, as described above, as well as enhanced
activation of adipose tissue. In the newborn, abdominal adipose is important for
nonshivering thermogenesis and is regulated by UCP1. By increasing UCP1 expression,
the fetus ensures adequate thermogenesis in the event of birth into oxygen limited
conditions. UCP1 expression is regulated by cortisol and T3, and increases in HSD11β1
and DIO2 indicate increased capacity for local synthesis and regulation by these
hormones in the adipose tissue. This enhanced brown fat phenotype in anticipation of
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birth into a potentially hostile environment creates a balance between the upregulation of
the HP axis while downregulating adrenal responsiveness to maintain basal levels.
These changes in the LTH fetus, however, are not maintained postnatally. After
birth, LTH lambs lose their brown fat phenotype; Ducsay, et al. (49) and Symonds, et al.
(170) showed that expression of UCP1, PGC1α, and PRDM16 decrease post birth,
implying a lineage derived from WAT, not BAT. Although the beige fat phenotype
initially is protective of adiposity, as the fetus expresses as brown fat, decreases in UCP1,
PGC1α, and PRDM16 suggest a predisposition of the lamb to fat deposition. In the
transition from fetus to neonate, there is a shift toward an enhanced white fat phenotype
which may result in greater adiposity as the newborn matures; decreased BAT has been
shown to result in obesity and related metabolic disorders that develop later in life (79,
84, 162).
The combined increased PAT expression and release of leptin, increased
adrenocortical leptin receptor (OB-Rb) expression, and increased zona fasciculataspecific eNOS expression and activity (NO release) would limit the ability of elevated
fetal plasma ACTH to stimulate cortisol production under basal conditions. Overcoming
these mechanisms may allow for increased synthesis and release of cortisol in response to
an acute secondary stressor.

Conclusions
The influence of hypoxia on the developing fetus has clearly been shown in the
HPA and adipose tissue in the ovine model. A variety of other studies have shown
changes in response to hypoxia in the macaques as well as the human. Hypoxia in the

17

human fetus has been associated with both maternal and fetal conditions including high
altitude, maternal heart disease or pulmonary hypertension, preeclampsia, and placental
insufficiency. These conditions often result in intrauterine growth restriction (IUGR),
preterm delivery, or stillbirth (1, 63, 71, 73, 88, 100, 126, 139). Maternal smoking also
leads to hypoxia in the human and has been associated with intrauterine growth
restriction (8, 52, 96, 155, 181, 184); low birth weight is a significant risk factor for the
development of obesity, hypertension, and type 2 diabetes (10, 13, 66, 67, 143, 163).
Studies in a nonhuman primate model, Japanese macaques, show that a high fat diet
reduces uterine volume blood flow, resulting in undernourished fetuses and an increased
incidence of stillbirth (55). These studies show a dramatic effect of hypoxia on the
growth potential of the fetus by either preventing full development, or predisposing the
fetus to numerous detrimental disorders.
The sheep has emerged as a major model for studying the effects of hypoxia on
the fetus. When challenged with an acute stress, the fetal HPA axis is activated to release
cortisol to counteract the perturbation and return the fetus to homeostasis.
Sympathoadrenal inhibition of insulin secretion in response to hypoxia ensures adequate
glucose for essential functions to restore homeostasis. In the case of a chronic stress, such
as long-term hypoxia, several studies have shown the remarkable ability of the fetus to
adapt to circumvent growth restriction and preterm birth.
Hypoxia is a potent stressor that commonly affects the developing fetus and can
cause adaptations in both the HPA axis as well as the adipose tissue. In the LTH fetus,
the HPA adapts such that despite the upregulation of hypothalamic CRH/AVP and
pituitary ACTH under basal conditions, adrenal production of cortisol is maintained at
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normoxic levels. However in response to an acute secondary stressor, the production of
cortisol is enhance beyond the stress response in normoxic controls. This proposes an
adaptation of the system that maintains cortisol levels required for growth and
development, but is combined with a programmed heightened response to acute stress.
This mechanism may be mediated by NO production in adrenal cortical cells, but also by
leptin production in fetal PAT. Both are capable of inhibiting cortisol synthesis, however
the exact mechanisms are still undetermined. NO may interact with steroidogenic
enzymes to reduce cortisol biosynthesis, while leptin may reduce adrenal responsiveness
to ACTH.
In adipose tissue, there is a unique beige phenotype developed in response to
chronic hypoxia. There is an upregulation of expression of BAT phenotypic genes,
UCP1, DIO2, HSD11B1, PPARγ, and PGC1α that would ensure adequate nonshivering
thermogenesis and indicate reduced adiposity. These genes, however, become
downregulated after birth, shifting toward a WAT phenotype and predisposing the
newborn to fat deposition. If the fetus were born into a hypoxic environment, this
adaptation may be beneficial, but in a normoxic environment, this could have a
significant detrimental life-long impact resulting in a variety of metabolic disorders
including obesity and diabetes.
As briefly described above, NO plays a major role in steroidogenesis. Below is a
detailed description of NO and the impact of hypoxia on NO production. It also describes
the mechanisms of action of NO on steroidogenesis and mechanisms of regulation of
eNOS.
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Nitric Oxide
Nitric oxide (NO) is a diatomic free radical molecule that diffuses feely across
cell membranes and is oxidized to nitrite (NO2-) and nitrate (NO3-) under physiological
conditions (56, 93, 105). NO has a wide range of physiologic functions including smooth
muscle relaxation and neurotransmission (124, 125, 180). NO is synthesized from Larginine by a family of nitric oxide synthases (NOS) (82); constitutively expressed
neuronal NOS (nNOS/NOS-I) and endothelial NOS (eNOS/NOS-III) and inducible NOS
(iNOS/NOS-II). Regulation of eNOS and nNOS are Ca2+/calmodulin-dependent, while
regulation of iNOS is Ca2+/calmodulin-independent (117). NO produced by eNOS and
nNOS regulate physiologic functions while iNOS tends to be invoked in pathological
situations.
Classically, NO-mediated cellular signaling is regulated via activation of soluble
guanylate cyclase (sGC). In his review, Ignarro describes how NO binds to the heme
group of guanylate cyclase to alter enzyme conformation and increase its activity (81).
This leads to elevation of intracellular cyclic guanosine monophosphate (cGMP)
followed by activation of protein kinase G (PKG). Although these actions of NO have
been best studied in vascular relaxation, it has been shown that guanylate cyclase
inhibitors do not fully block the vasorelaxant effects of NO, indicating a cGMPindependent component of NO activity (41).
Aside from vasorelaxation, a variety of cGMP-independent effects of NO have
been studied, including the inhibition of steroidogenesis; Drewett et al., determined
cGMP-independent NO inhibition of key rate-limiting steps in the steroidogenic pathway
(45). Changes in NO have been shown to affect steroidogenesis in a variety of tissues
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including inhibition in ovarian tissue of women (178), pigs (112, 113), rabbits (65, 186),
and rats (120), while inhibition of NOS increased testosterone production in Leydig cells
(44). In adult rat testis, immobilization stress increased NO and reduced the production of
testosterone (97) and NO inhibited cortisol secretion (3). In the adrenal, NO inhibited
basal, ACTH, and angiotensin II-induced aldosterone production in the adult rat (74, 75)
and bovine adrenal cortical cells (76), while NOS inhibition increased aldosterone in
humans (127). Also in the adrenal, NO donors decreased corticosterone production and
NOS inhibition enhanced glucocorticoid output (38, 39). These studies show that changes
in NO production affect steroidogenesis in multiple tissue types, including adrenal cells.
In our lab, we have shown that NO inhibits cortisol biosynthesis and that inhibition of
NOS enhances cortisol output in ovine LTH FACs (123). Together this suggests that the
regulation of nitric oxide production may be important to the fetal adaptation to LTH.
Due to the short half-life of NO, the site and source of NO production must be
close to the target cells for inhibition to occur. In the adrenal, nNOS has been shown to
increase in the rat cortex following immobilization stress (95, 138), and eNOS expression
has been demonstrated in the rate zona glomerulosa (40, 138) and fasciculata (40), as
well as the adult sheep fasciculate (148). NOS mRNA was also detected in the near term
rat pup (4). Our lab has identified robust eNOS, but minimal amounts of nNOS and iNOS
expression in the ovine fetal adrenal, with the greatest density of eNOS in the cortisol
producing zona fasciculata/reticularis area in both normoxic and LTH adrenal sections.
We also found greater eNOS protein expression in the LTH compared to normoxic
adrenals, colocalizing with CYP17, identifying eNOS expression in cortisol producing
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cells (122). Together this implies that eNOS plays a major role in the fetal adaptation to
LTH through direct interaction of NO within FACs.

Hypoxia and NO Production
Regulation of steroidogenesis by hypoxia has been clearly shown by Raff et al.,
(153, 154), and Hanke and Campbell demonstrated that reducing oxygen concentrations
resulted in a lower threshold for NO-mediated inhibition of aldosterone synthesis in adult
rat adrenals (74). Due to this regulation, NO represents a potential mechanism in the
adrenocortical adaptation to LTH, and as the predominant NOS isoform in the ovine fetal
adrenal cortex and increased in the LTH adrenal, eNOS is a potential target for adapted
regulation of steroidogenesis in the LTH ovine fetus.
Hypoxia has a wide range of effects on NO production (and/or expression of NOS
isoforms) in different animal models and tissues. Justice et al., showed that hypoxia
increased eNOS expression and NO production in micro vessels in the heart of pigs (91),
and Xiao found that LTH enhanced eNOS expression in ovine uterine arteries (185). In
cerebral arteries, Williams et al., determined that hypoxia reduced eNOS expression but
increased components of the NO/cGMP/PKG pathway, increasing vascular sensitivity to
NO (183). Following hypoxia (5% O2 for 7 days), Murata et al., observed reduced eNOS
expression and function in cultured pulmonary arteries (130), and that hypoxia-induced
pulmonary hypertension impaired the interaction of eNOS with its regulatory proteins,
and thus reduced NO production (129). Thompson and Dong found that hypoxia may
have divergent effects on eNOS expression, with decreased fetal eNOS expression but
increased adult expression in guinea pig hearts (172). Hypoxia was shown by Chen and
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Meyrick to stimulate eNOS-Hsp90 interaction and activate the PI3K/Akt pathway,
leading to eNOS phosphorylation and increased NO production (30). These mixed results
suggest that the effects of hypoxia on eNOS regulation and NO production may be tissue
specific.
Hypoxia has also been shown to affect the regulatory pathways for both NO and
cortisol synthesis. Mishra et al., showed that administration of a NOS inhibitor prevented
hypoxia-induced phosphorylation of ERK in neuronal nuclei of newborn piglets,
suggesting NO mediates ERK phosphorylation in response to hypoxia (119). Zhu et al.,
showed that hypoxia enhanced ERK phosphorylation in endothelial cells (192), and
Onishi et al., showed that basal PKA activity in fetal hearts was increased in LTH fetuses
compared with normoxic controls (144). These changes in regulatory signaling pathways
could result in changes in steroid production.
Another signaling pathway that has been shown to be affected by hypoxia is
through Akt. Decreased oxygen resulted in increased AMP-activation of AMPK, and
hypoxia-induced AMPK/Akt-activation of eNOS was demonstrated in endothelial cells.
Akt was also shown to be the dominant kinase involved in eNOS phosphorylation at
Ser1177 in hypoxic endothelial cells, and direct AMPK phosphorylation of eNOS was
suggested to occur under conditions of prolonged hypoxia (137). The Ser1177/79 residue
on eNOS has been shown to be a substrate for both Akt (43, 57) and AMPK (31).
Typically this serine residue is referred to Ser1177/79 as Ser1177 refers to the human
residue while in the bovine/ovine it is Ser1179 (43, 57, 59). It was also shown that
AMPK phosphorylates eNOS at Ser633 and signals NO bioavailability (32). Changes in
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eNOS phosphorylation induced through these signaling pathways could affect eNOS
activity and NO synthesis, and they could be influenced by oxygen levels.

Mechanisms of NO Disruption of Steroidogenesis
Direct Effects
An alternative mechanism to NO/cGMP signaling may be through NO-heme
binding. Tsubaki et al., showed that NO is capable of competitively interacting with the
heme-oxygen binding site, similar to guanylate cyclase, and binds to key steroidogenic
enzymes CYP11A1 and CYP17 (174, 175). Peterson et al., suggested that because these
P450 enzymes use several round of attack of the heme-oxygen complex on the steroid
substrate, they may be more susceptible to NO inhibition than other enzymes (148).

Indirect Effects
Another potential mechanism of NO suppression of steroidogenesis is Snitrosylation of key Cys residues in critical steroidogenic proteins. CYP11A1 and CYP17
are key steroidogenic enzymes have critical Cys residues in their actives sites.
Modification of these Cys residues could play a role in their activity. Though largely
unexplored in steroidogenic CYPs, Lee et al., reported CYP S-nitrosylation in liver (103).
Zinc finger transcription factor SF-1, responsible for transcription of CYP11A1 and
CYP17 and StAR (165, 191), is another target for NO-mediated S-nitrosylation. Snitrosylation of Zn+ finger transcription factors results in the loss of Zn+ from the DNA
binding pocket, disrupting their function as transcriptional activators (60, 98).
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Mechanisms of eNOS Regulation
Regulation of eNOS can occur through post-translational mechanism including
protein-protein interactions and phosphorylation (50). Interaction with Ca2+/calmodulin
can activate eNOS (117), as well as interaction with Caveolin-1 (Cav-1) and heat shock
protein 90 (Hsp90) (29, 30, 68). Gratton et al., showed that Cav-1 keeps eNOS in an
inactive state at the caveolae while inhibiting eNOS translocation and/or the stimulatory
actions of calmodulin binding. Hsp90 binds soluble eNOS and may disrupt the Cav1/eNOS complex, enhancing NOS activity (68).
Another method of eNOS regulation is through phosphorylation. There are
multiple signaling pathways that may be involved in the phosphorylation of eNOS
including MEK/ERK1/2 and PI3K/Akt, as well as Ca2+/calmodulin, AMPK, PKA, PKC,
and ERKs (14, 15, 30-32). We have already shown that basal Akt and ERK1/2
phosphorylation are elevated in the LTH fetal adrenal , and that regulation of ERK1/2 is
able to affect cortisol production (179). The role of ERK1/2 on NOS expression and
activity is controversial but evident in various tissues. Cale and Bird showed that
inhibition of ERK1/2 upregulated ATP-stimulated eNOS activity but inhibited ATPstimulated activity in COS-7 cells (22), while Chen and Meyrick showed that
MEK/ERK1/2 inhibition enhanced eNOS activity in porcine pulmonary arteries (30). A
variety of other studies have shown that MEK/ERK1/2 pathway inhibition reduces eNOS
phosphorylation and NO production in multiple cell types (29, 109, 118, 121). Studies
have also shown that eNOS phosphorylation can be altered through the PI3K/Akt
pathway (57, 77, 118).
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At present however, the potential role of these signaling pathways in eNOS
regulation and NO production have not been explored. More importantly, information on
the novel role of hypoxia in this regulatory process is lacking. This gap in our knowledge
has served as the major focus of our current work.

Signaling Pathways and Steroidogenesis
ERK1/2 stimulation has been shown to affect steroidogenesis through
upregulation of StAR expression (72), and we have shown that inhibition of ERK1/2
reduces cortisol production in fetal adrenocortical cells, with a greater effect in LTH
FACs (179). It has also been shown that inhibition of the PI3K/Akt pathway reduced
stimulated steroid production in multiple cell types including ovaries, testes, and adrenals
(106, 146).
In the LTH fetus, we showed that NOS activity was significantly greater in LTH
vs normoxic and that ACTH treatment significantly reduced NOS activity in LTH with
no effect in normoxic, returning activity to levels observed in normoxic (123). Together
with NO-stimulated inhibition of cortisol synthesis and enhanced cortisol in response to
NOS inhibition, this may be a mechanism of regulating cortisol responses under
conditions of LTH. Upregulation of adrenal eNOS in the LTH group may be responsible
for enhanced basal NOS activity which would exert an inhibitory effect on basal cortisol
production overcoming low level stimulation by elevated basal ACTH. Stress levels of
ACTH would decrease NOS activity, enhancing cortisol output. The mechanisms
involved in LTH regulation of adrenal eNOS and associated NO along with the
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mechanisms via which NO modulates cortisol production may include key signaling
pathways MEK/ERK1/2 and PI3K/Akt.
Based on the work in our laboratory and that of others, the following model of the
potential role of NO in the regulation of cortisol biosynthesis under conditions of LTH
has been developed (Figure 1).
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Figure 1. Schematic diagram of eNOS regulation in the LTH adrenal cortex. LTH results
in increased activation of PI3K, AMPK, and Ras signaling pathways. Activation of PI3K
and/or AMPK results in elevated pAkt/Akt which we hypothesize results in increased
activity of eNOS via phosphorylation of eNOS at Ser1177/79 and dissociation of Cav-1
and recruitment of the eNOS activator, Hsp90. Activated eNOS results in NO generation
leading to Cys S-nitrosylation of critical target proteins governing cortisol synthesis
(CY11A1, CYP17), and SF-1, which regulates CYP11A1/17 transcription. We
hypothesize that S-nitrosylation of Cys residues in the DNA binding domain of SF-1
reduces its capacity to interact with specific SF-1 cis elements in the promoter regions of
CYP11A1/17 while nitrosylation of CYP11A1/17 decreases enzyme activity. These
hypotheses are consistent with decreased cortisol synthesis and CYP expression observed
in the adrenal cortex of LTH fetal sheep in spite of elevated basal plasma ACTH. However,
under conditions of a secondary stressor, large increases in ACTH (~10-20 fold over basal
levels) override the inhibitory effects of NO and result in enhanced cortisol production
compared to normoxic.
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Under basal conditions, despite increased hypothalamic drive, cortisol output
remains normal in the LTH fetus. In response to a secondary stressor, this
biochemical/molecular “brake” on cortisol production can be overridden, allowing the
LTH fetus to mount an enhanced response. NO, through regulation of NOS may be one
of the key factors involved in adapted regulation of cortisol in response to LTH. The
following studies were designed to define the mechanisms involved in this adaptive
response. This project addressed the role of key signaling pathways MEK/ERK1/2 and
PI3K/Akt, as well as Ca2+, governing eNOS activity in the ovine fetal adrenal, the effect
of NO on key steroidogenic enzymes, and the role of eNOS in cortisol biosynthesis in the
fetal adaptation to LTH. The expression and phosphorylation of eNOS at Ser1177/79, one
primary phosphorylation site governing eNOS activity, and cortisol production was
investigated in response to MEK/ERK1/2 or PI3K/Akt pathway inhibition, or Ca2+
induction accompanied by secondary stress stimulation with ACTH. NO supplementation
and eNOS inhibition were used in combination with ACTH stimulation to determine the
role of NO on the expression of CYP11A1, CYP17, StAR, and ACTH-R mRNA as well
as cortisol production in both normoxic and LTH FACs.
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Abstract
This study was designed to determine the role of the MEK/ERK1/2 and PI3K/Akt
pathways in cortisol production and endothelial nitric oxide synthase (eNOS)
phosphorylation (peNOS) in the ovine fetal adrenal in response to long-term hypoxia
(LTH). Pregnant ewes were maintained at high altitude (3820 m) for the last 100 days of
gestation (dGa). At 138 to 142 dGa, fetal adrenal cortical cells (FACs) were collected
from LTH and age-matched normoxic fetuses. Cortisol production and peNOS were
measured in response to pretreatment with the MEK/ERK1/2 pathway inhibitor UO126
(UO) and adrenocorticotropic hormone (ACTH) stimulation. UO126 reduced ACTHstimulated cortisol in both normoxic and LTH FACs. UO126 alone or in combination
with ACTH reduced peNOS in the normoxic group, while ACTH alone or ACTH + UO
inhibited peNOS in LTH FACs. Additionally, cortisol was measured in response to
pretreatment with UO and treatment with 22R-hydroxycholesterol (22R-OHC) or watersoluble cholesterol (WSC) with and without ACTH stimulation. UO126 had no effect on
22R-OHC–treated cells, but reduced cortisol in cells treated with WSC and/or ACTH.
Cortisol and peNOS were also measured in response to pretreatment with PI3K/Akt
pathway inhibitor Wortmannin (WT) and ACTH stimulation. Wortmannin further
increased cortisol under ACTH-stimulated conditions and, like ACTH, reduced peNOS in
LTH but not normoxic FACs. Together, these data suggest that in LTH FACs
MEK/ERK1/2 does not regulate peNOS but that UO acts downstream from eNOS,
possibly at cholesterol transport, to affect cortisol production in LTH FACs, while the
PI3K/Akt pathway, along with ACTH, regulates peNOS and plays a role in the fetal
adaptation to LTH in FACs.
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Introduction
Hypoxia is a potent stressor that activates the hypothalamo-pituitary-adrenal
(HPA) axis, and acutely, leads to a significant increase in cortisol (1-3, 19, 20). Since
cortisol is involved in lipolysis, glycogenolysis, and protein catabolism, a sustained
elevation of plasma cortisol concentrations can suppress anabolic processes resulting in
muscle atrophy and delayed maturation and organ growth (26, 34). Therefore, under
conditions of chronic stress, the ability of the fetal HPA axis to adapt to limit cortisol
production is crucial for maintaining normal development during gestation. The
regulation of cortisol must also be effectively coordinated to permit the late gestation
exponential rise in fetal plasma cortisol essential for fetal maturation, while permitting
episodic cortisol production in response to acute stress.
In our laboratory, we have clearly shown the ability of the fetal HPA axis to adapt
to the chronic stress of long-term moderate gestational hypoxia (LTH). In this model, the
fetus develops under high altitude induced (3820 m from approximately day 40 of
gestation) moderate hypoxia (fetal PO2 ~17-19 mmHg vs. ~21-23 mmHg normoxic
controls). Under conditions of LTH, the fetus maintains normal basal plasma cortisol
concentrations despite elevated adrenocorticotropic hormone (ACTH) (35). Although we
found no differences in cyclic adenosine monophosphate (cAMP) production or protein
kinase A (PKA) activation either basally or in response to ACTH in LTH fetal
adrenocortical cells (FACs), we did observe decreased expression of CYP11A1 and
CYP17, two key steroidogenic P450 enzymes, as well as decreased ACTH receptor
expression (36). When combined, this may contribute to maintaining basal cortisol levels
in the LTH fetus. In contrast to basal conditions, the LTH fetus displays a heightened
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cortisol response to an acute secondary stressor compared to normoxic fetuses (1, 19).
Thus, the LTH fetus has developed a mechanism of regulation that maintains basal
plasma cortisol, despite elevated basal ACTH, but allows the fetus to overcome this
suppression for an enhanced cortisol response to an acute secondary stress.
One possible effector of cortisol regulation in this system is nitric oxide (NO), a
diatomic free radical gas with a variety of physiological functions that is produced from
L-arginine by NO synthases (NOSs) (18, 33). We have previously shown that NO
inhibits ACTH-stimulated cortisol production in LTH ovine FACs and that endothelial
NOS (eNOS) inhibition enhances LTH FAC cortisol biosynthesis (32). We have also
demonstrated that eNOS is the most abundant isoform of NOS in the ovine fetal adrenal
cortex, and that expression of eNOS is enhanced in LTH adrenals compared to normoxic
controls (31), consistent with the observed dissociation between elevated plasma ACTH
and normal basal output of cortisol. However, in line with enhanced ACTH and stressstimulated cortisol production in the LTH fetus, ACTH treatment significantly reduced
eNOS activity in LTH FACs compared to normoxic (32).
A key mechanism involved in the regulation of eNOS is phosphorylation at a
serine activation site. In the human, it is serine residue 1177, and in the bovine/ovine it is
serine residue 1179, typically referred to as Ser1177/79 (10, 14, 15). A reduction in
phosphorylation at this residue could be the result of either decreased kinase activation or
active dephosphorylation (4, 7, 16). Both of these potential mechanisms would lead to a
reduction in NOS activity, with a resultant decrease in NO production. This in turn would
allow for increased cortisol biosynthesis under ACTH-stimulated conditions in the LTH
fetal adrenal. Phosphorylation at this site may be affected by different cell signaling
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pathways including MEK/ERK1/2 and PI3K/Akt. Various studies have shown that
inhibition of the MEK/ERK1/2 pathway with UO126 (UO) reduces eNOS
phosphorylation and NO production in a variety of cell types (5, 23, 28, 30). Other
studies have shown that the PI3K/Akt pathway also targets eNOS at Ser1177/79 in
endothelial cells (14, 17, 28). The roles of the MEK/ERK1/2 and the PI3K/Akt pathways
in eNOS activation and in the context of LTH in ovine FACs have yet to be examined.
However, we have shown that NO clearly inhibits basal and ACTH-induced cortisol
synthesis in ovine FACs (32). Paradoxically, we observed that inhibition of
MEK/ERK1/2 signaling with UO did not have the predicted enhancement of basal or
ACTH-induced cortisol synthesis but rather inhibited ACTH-induced cortisol synthesis
(43), suggesting that while MEK/ERK1/2 may target eNOS in these cells, it has
additional pathways that may predominate in regulating cortisol synthesis.
In light of these findings, UO has also been shown to block steroidogenesis in
both granulosa (9) and Leydig (25, 38) cells. This may be through effects on
steroidogenic acute regulatory (StAR) protein, which transports cholesterol into the
mitochondria (8, 21, 24, 39-41); inhibition of StAR activity would prevent cortisol
biosynthesis. These studies showed that UO inhibited synthesis of steroid in both
stimulated cells and cells supplemented with water-soluble cholesterol (WSC), both of
which require cholesterol transport into the mitochondria for steroidogenesis. However,
steroid production was unaffected in cells treated with 22R-hydroxycholesterol (22ROHC), a mitochondrial membrane permeable form of cholesterol that does not require
facilitative transport. Therefore, although MEK/ERK1/2 may have a major role in
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cholesterol transport in FACs, the role of LTH on this process has not yet been
determined in ovine FACs.
The present study was designed to 1) determine if either the MEK/ERK1/2 or
PI3K/Akt pathways regulate eNOS phosphorylation in FACs, 2) address the role of
MEKERK1/2 in facilitating cholesterol transport to the mitochondria, and 3) determine
the potential adaptive alterations in these pathways in response to LTH.

Materials and Methods
Animals
Time-dated pregnant ewes were maintained at the Barcroft Laboratory White
Mountain Research Station (3820m, maternal PO2 ~ 60mmHg) from approximately day
40 of gestation to near term (term  146 days). Following transportation to the laboratory,
hypoxia was maintained by nitrogen infusion through a maternal tracheal catheter as
previously described (1, 12, 19, 32, 42). Age-matched, normoxic ewes served as controls.
On days 138-142 of gestation, ewes were sedated and maintained under general
anesthesia while fetuses were delivered through midline laparotomy. Procedures were
performed as previously described in detail (29). Fetal adrenal glands were collected in
ice-cold media M-199 (Sigma-Aldrich, St. Louis, MO), containing 2.2 g sodium
bicarbonate, 2.0 g bovine serum albumin (BSA), and 0.1 g L-glutamine for cell
dispersion and subsequent study. All procedures were conducted with the approval of the
Institutional Animal Care and Use Committees (Loma Linda University School of
Medicine, Loma Linda, CA).
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Cell Dispersion
Procedures for collection of FACs were similar to those we previously
described.(42, 43) Briefly, fetal adrenal glands were divided in half along the longitudinal
axis and the cortex was separated from the medulla. The cortical tissue was minced and
enzymatically dispersed with 40 mg collagenase Type II (Worthington Biomedical,
Lakewood, NJ), 40 mg of Polypep bovine protein digest (Sigma-Aldrich) and 100 µl of
DNAse I (Type IV) (Sigma-Aldrich) dissolved in 10 ml of Sodium Krebs Buffer (0.4%
collagenase). The resulting mono-dispersed FACs were aliquoted into individual tubes
with media (M-199), and allowed to equilibrate for 2 hours at 37°C prior to initiation of
each study as required by each experimental protocol. Cell viability was confirmed by
Trypan blue exclusion.

Treatment Protocols
Effects of MEK/ERK1/2 Inhibition and ACTH Stimulation on Cortisol Biosynthesis
and eNOS Phosphorylation
FACs from normoxic (n=7) and LTH (n=5) fetuses, aliquoted at 7.5x105
cells/1mL, were untreated, pretreated with MEK/ERK1/2 inhibitor UO126 (UO, 10 µM)
for 1 hour, or stimulated with ACTH (100 pM), with and without UO pretreatment.
Media and cells were collected at 0 (baseline), 10, 20, and 60 minutes after stimulation.
Media was immediately frozen in liquid nitrogen, and stored at -80°C until determination
of cortisol. Cells were lysed in 80 µL of lysis buffer (93% prelysis buffer [1 mM Trizma
Base, 10 mM NaCl, 0.1 mM EDTA, 0.1 mM EGTA, 1% Triton X-100, 0.5% Igepal CO630, 20 mM NaF], 1% 100 mM phenylmethanesulfonyl fluoride [PMSF], 1% Protease
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Inhibitor Cocktail [PIC, Sigma, St Louis, Missouri], 5% 20 mM sodium orthovanadate),
frozen in liquid nitrogen, and stored at -80°C until analysis.

Effects of UO126 Pretreatment and ACTH, 22R-OHC, or WSC Stimulation on
Cortisol Biosynthesis
This experiment was designed to examine the interaction between inhibition of
the MEK/ERK1/2 pathway with UO126 and cholesterol transport across the
mitochondrial membrane. FACs from normoxic (n=6) and LTH (n=7) fetuses, aliquoted
at 2.5x105 cells/mL, were either untreated, pretreated with UO (10 µM) for 1 hour, or
stimulated with ACTH (100 pM) with and without UO pretreatment, treated with
membrane permeable 22R-hydroxycholesterol (22R-OHC, 10 µM), with and without UO
pretreatment, treated with water-soluble cholesterol (WSC, 10 µM), with and without UO
pretreatment, or a combined stimulation of ACTH and 22R-OHC treatment or ACTH and
WSC treatment with and without UO pretreatment. The membrane permeable form, 22ROHC does not require transport across the mitochondrial membrane whereas WSC is
transport dependent. Media was collected at 60 minutes after stimulation and stored as
described above for later cortisol analysis.

Effects of PI3K/Akt Inhibition and ACTH Stimulation on Cortisol Biosynthesis and
eNOS Phosphorylation
FACs from normoxic (n=7) and LTH (n=9) fetuses, aliquoted at 7.5x105
cells/1mL, were either untreated, pretreated with PI3K/Akt inhibitor Wortmannin (WT,
10 nM) for 1 hour, or stimulated with ACTH (100 pM), with and without WT
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pretreatment. Media and cells were collected at 0 (baseline), 10, 20, and 60 minutes after
stimulation and stored as described above. We chose to use Wortmannin instead of
LY294002 because in preliminary studies, the LY compound dramatically reduced FAC
viability.
Cortisol Assay
Cortisol was measured using a commercially available enzyme-linked
immunosorbent assay (ELISA) cortisol kit (Oxford Biomedical Research, Oxford, MI)
that has been previously described and validated for use in our laboratory (13, 32, 36).

Western Analysis
Endothelial nitric oxide synthase protein was analyzed from FACs collected at 0
(baseline), 10, 20, and 60 minutes for both normoxic and LTH groups, described above.
Samples were thawed and protein concentration was determined using a bicinchoninic
acid (BCA) protein assay (Thermo Scientific, Rockford, Illinois) with BSA as the
standard. Absorbance was measured at 595 nm on a BioTek Synergy HT Multi-Mode
Microplate Reader (Winooski, Vermont).
Endothelial nitric oxide protein phosphorylation was determined by Western
blotting using methods we have previously described and validated.(35, 36) Briefly,
protein samples were denatured for 5 minutes at boiling temperature and 20 µg of protein
were loaded per lane. Protein samples were separated using 7.5% polyacrylamide gels
(Bio-Rad, Hercules, CA) and subjected to electrophoresis (SDS-PAGE) and then
transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA)
using a Transblot cell apparatus (Bio-Rad).
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To determine the level of eNOS protein phosphorylation, the membranes were
incubated with a rabbit monoclonal phospho-eNOS (Ser1177) (C9C3) primary antibody
(Cell Signaling, Product#9570) in 10 mL 5% BSA TBST solution (1:1000) overnight at
4°C. Membranes were then incubated with goat anti-rabbit polyclonal secondary
antibody (ThermoScientific, Product#35571) in 10 mL 5% BSA TBST solution
(1:10000) for 90 minutes, washed, and imaged with a Licor Odyssey scanner at 700 nm.
The relative optical densities (ROD) of the bands were used to compare normoxic to LTH
phosphorylated eNOS (peNOS) protein expression. An internal positive standard
prepared from whole fetal adrenal tissue was used to normalize peNOS protein.
To determine the level of eNOS protein expression, the membranes were first
stripped of phosphorylated antibody and incubated with mouse anti-eNOS primary
antibody (BD Transduction, Product# 610296) in 10 mL 5% NFDM TBST solution
(1:250) overnight at 4°C. Membranes were then incubated with goat anti-mouse
polyclonal secondary antibody (Thermo Scientific, Product# 35518) in 10 mL 5% NFDM
TBST solution (1:20000) for 90 minutes, washed, and imaged with a Licor Odyssey
scanner at 800 nm. The RODs of the bands were used to compare normoxic to LTH
eNOS protein expression. An internal positive standard prepared from whole fetal adrenal
tissue was used to normalize eNOS protein as we have previously described in our
laboratory (31, 43).

Statistical Analysis
Descriptive statistics are presented as mean ± standard error. Data analysis was
performed using repeated measures analysis of variance (ANOVA) with 1 between-
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subject factor (treatment) and 1 within-subject factor (time) stratified by oxygenation
level (normoxic or LTH). The main effect tested was in vitro treatment (WT or UO). For
the cholesterol study, 2-way ANOVA was used with oxygenation level (normoxic or
LTH) tested across cholesterol treatment. Alpha was set at .05 significance level. Post
hoc tests were adjusted using the Bonferroni method. Statistical analyses were performed
using IBM SPSS Statistics (Version 22; IBM Corporation, 2013).

Results
Effects of MEK/ERK1/2 Inhibition and ACTH Stimulation
Cortisol Production
There were no differences observed in cortisol production from either control or
LTH FACs that were pretreated with UO compared to the untreated cells, and cortisol
levels remained relatively constant throughout the 60 minutes of study (Figure 1). There
was a significant increase in cortisol output from both normoxic (4.49 +/- 0.89 ng/mL)
and LTH (13.25 +/- 0.78 ng/mL) FACs; in control normoxic FACs, cortisol was
significantly elevated by 60 minutes after ACTH stimulation (p<0.05), while a significant
increase in cortisol output was observed in LTH FACs in response to ACTH by 10
minutes. Pretreatment with UO inhibited the stimulated increase in cortisol in both
normoxic and LTH FACs compared to ACTH alone (p<0.05).

Expression of eNOS
Treatment with ACTH and UO pretreatment had no effect on expression of eNOS
protein in either LTH or control FACs (Figure 2A).
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Phosphorylation of eNOS
In normoxic FACs, all three treatments resulted in a similar reduction in peNOS.
In contrast, LTH FACs demonstrated a significant reduction in peNOS in the ACTH
treated groups (UO + ACTH or ACTH alone) compared to untreated FACs (p<0.05).
This reduction was similar in both groups (Figure 2B).

Effects of UO126 and ACTH, 22R-OHC, and WSC Stimulation on Cortisol Production
Treatment with either ACTH and 22R-OHC, or ACTH and WSC resulted in
enhanced cortisol production in FACs from both normoxic and LTH groups compared to
respective untreated controls (p<0.05) while the effect was greater in the LTH group
compared to the normoxic group (p<0.05) (Figure 3). Pretreatment with UO blocked the
ACTH and WSC stimulated increase but had no effect on cortisol production in cells
stimulated with 22R-OHC in either normoxic or LTH FACs (Figure 3).

Effects of PI3K/Akt Inhibition and ACTH Stimulation
Cortisol Production
Pretreatment with WT alone had no effect on cortisol biosynthesis compared to
untreated control FACs in both normoxic and LTH FACs, and cortisol levels remained
relatively constant throughout the 60 minutes of study (Figure 4). There was a significant
increase in cortisol production by 60 minutes (p<0.05) in cells stimulated with ACTH in
both normoxic (7.54 +/- 1.37 ng/mL) and LTH (8.85 +/- ng/mL) FACs. ACTH cells
pretreated with WT demonstrated significantly enhanced cortisol production in both
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normoxic (12.42 +/- 1.96 ng/mL) and LTH (26.18 +/- 4.48 ng/mL) compared to ACTH
alone (p<0.05).

Expression of eNOS
No differences were observed in eNOS expression between treatment groups in
both normoxic and LTH FACs (Figure 5A).

Phosphorylation of eNOS
There were no significant changes in phosphorylation between treatment groups
in the normoxic FACs (Figure 5B). In LTH FACs, there was a significant reduction in
phosphorylation with WT pretreatment, ACTH stimulation, and combined pretreatment
and stimulation compared to untreated FACs (p<0.05). This reduction was similar, with
no differences observed among WT, ACTH, or WT+ACTH groups.
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Figure 1. Time course of cortisol production in normoxic and LTH FACs with
MEK/ERK1/2 inhibition and ACTH stimulation. Treatment with ACTH (100pM)
increased cortisol production in both normoxic and LTH FACs. Pretreatment with UO
(10µM) had no effect on basal cortisol, but prevented increased cortisol biosynthesis in
response to ACTH stimulation in both normoxic and LTH FACs. (Normoxic n=7, LTH
n=5) Values represent mean values ± SEM. *p<0.05 compared to time 0. FACs, fetal
adrenocortical cells; LTH, long-term hypoxia; UO, UO126; ACTH, adrenocorticotropic
hormone.
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Figure 2. Protein expression (A) and phosphorylation (B) of eNOS in response to
MEK/ERK1/2 inhibition and ACTH stimulation in normoxic and LTH FACs as
determined by Western analysis. Pretreatment with UO (10µM) with and without ACTH
(100pM) stimulation had no effect on eNOS in both normoxic and LTH FACs.
Pretreatment with UO (10µM) had no effect on peNOS in both normoxic and LTH FACs.
Treatment with ACTH had no effect on peNOS in normoxic FACs but decreased peNOS
in LTH FACs (p<0.05 compared to untreated LTH FACs; Normoxic n=7, LTH n=5).
Values represent mean values ± SEM. *p<0.05 compared to control. FACs, fetal
adrenocortical cells; LTH, long-term hypoxia; eNOS, endothelial nitric oxide synthase;
peNOS, phosphorylated endothelial nitric oxide synthase; ROD, relative optical density;
UO, UO126; ACTH, adrenocorticotropic hormone.
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Figure 3. Cortisol production in response to UO126 pretreatment and 22R-OHC or WSC
stimulation with or without ACTH in normoxic and LTH FACs. ACTH (100pM), 22ROHC (10µM), and WSC (10µM) stimulation increased cortisol production in both
normoxic and LTH FACs, with a greater increase in dual stimulated cells. Pretreatment
with UO blocked cortisol increase in cells stimulated with ACTH and WSC but had no
effect on cells stimulated with 22R-OHC in both normoxic and LTH FACs. (Normoxic
n=6, LTH n=7) Values represent mean values ± SEM. *p<0.05 compared to untreated
control, #p<0.05 compared to normoxic. FACs, fetal adrenocortical cells; LTH, long-term
hypoxia; C, Control; UO, UO126; ACTH, adrenocorticotropic hormone; 22R-OHC, 22Rhydroxycholesterol; WSC, water-soluble cholesterol.
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Figure 4. Time course of cortisol production in normoxic and LTH FACs with PI3K/Akt
inhibition and ACTH stimulation. Treatment with ACTH (100pM) increased cortisol
production in both normoxic and LTH FACs. Pretreatment with WT (10nM) had no effect
on basal cortisol but enhanced cortisol biosynthesis in response to ACTH stimulation in
both normoxic and LTH. (Normoxic n=7, LTH n=9) Values represent mean values ± SEM.
*p<0.05 compared to time 0. FACs, fetal adrenocortical cells; LTH, long-term hypoxia;
WT, Wortmannin; ACTH, adrenocorticotropic hormone.
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Figure 5. Protein expression (A) and phosphorylation (B) of eNOS in response to
PI3K/Akt inhibition and ACTH stimulation in normoxic and LTH FACs as determined by
Western analysis. Pretreatment with WT (10nM) with and without ACTH (100pM)
stimulation had no effect on eNOS in both normoxic and LTH FACs. Pretreatment with
WT (10nM) with and without ACTH (100pM) stimulation had no effect on peNOS in
normoxic FACs but reduced peNOS in LTH FACs. (Normoxic n=7, LTH n=9) Values
represent mean values ± SEM. *p<0.05 compared to control. FACs, fetal adrenocortical
cells; LTH, long-term hypoxia; eNOS, endothelial nitric oxide synthase; peNOS,
phosphorylated endothelial nitric oxide synthase; ROD, relative optical density; WT,
Wortmannin; ACTH, adrenocorticotropic hormone.
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Discussion
The regulation of cortisol is a crucial component of fetal development due to its
involvement in catabolic processes; chronically high levels of cortisol can suppress
anabolic processes, which can prevent normal tissue growth and maturation of the fetus
(26, 34). The ovine fetus demonstrates a divergent adaptive response of the HPA axis to
LTH. At the level of the hypothalamus and anterior pituitary, there is clearly an activation
of the stress response with enhanced proopiomelanocortin (POMC) processing to ACTH
coupled with elevated basal plasma ACTH levels in LTH fetuses compared to normoxic
controls (35). There is also a distinct up regulation of the ACTH response to AVP
compared to CRH in the LTH fetuses (13). In contrast to the hypothalamic and pituitary
responses, we showed that basal adrenal cortisol biosynthesis is normal despite the
elevated plasma ACTH.(1, 11, 19, 35) Surprisingly, the LTH fetus responds more
robustly, with enhanced cortisol production to a secondary stressor compared to the
normoxic fetus (1, 19), suggesting an adaptation in the HPA axis that maintains normal
basal levels but allows for enhanced production in response to stress.
We previously reported that NO inhibits ACTH-stimulated cortisol production,
while eNOS inhibition enhanced cortisol biosynthesis in LTH ovine FACs (32). We also
found that endothelial NOS (eNOS) is the most abundant adrenal cortical NOS isoform
and LTH enhanced not only expression of eNOS (31), but also NOS activity compared to
normoxic controls (32). Activity of eNOS can be influenced by a number of factors
including substrate availability, protein-protein interactions, and post-translational
modification via phosphorylation (6). In this study we address the ability of the cell
signaling kinase pathways MEK/ERK1/2 and PI3K/Akt to regulate eNOS activity via
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phosphorylation of Ser1177/79 to alter NO production that, in turn, could then affect
cortisol biosynthesis. We also addressed if the site of action of MEK/ERK1/2 on cortisol
synthesis in FACs was up- or downstream of cholesterol translocation into the
mitochondria, the site of the first rate-limiting step in steroidogenesis, since we
previously observed a major inhibition in ACTH-induced cortisol synthesis in FACs (43).
In a previous study we showed MEK/ERK1/2 inhibition reduced cortisol output
in FACs in response to stimulation with ACTH (43). In the present study, as in our
previously published report (43), we found that MEK/ERK1/2 inhibition with UO126
(UO) prevented the increase of cortisol in response to ACTH in both normoxic and LTH
FACs. While ACTH-stimulated cortisol production was inhibited in both normoxic and
LTH FACs, the ability of UO to almost completely prevent the enhanced cortisol
production in response to ACTH in the LTH FACs indicates that the adaptive response
seen in the LTH fetus is dependent upon MEK/ERK1/2 signaling. In the present study,
we also explored the effect of UO on eNOS expression or phosphorylation. UO126 alone
did not affect eNOS expression. In normoxic FACs, all 3 treatments (UO, ACTH and
ACTH + UO) reduced peNOS similarly over time. This suggests that ACTH itself is not
responsible for changes in eNOS phosphorylation in normoxic FACs. In contrast, in LTH
FACs, UO alone had no effect on peNOS. As predicted, however, ACTH significantly
reduced peNOS, and the same effect was observed with ACTH in the presence of UO.
Together with the cortisol data, these findings demonstrate that MEK/ERK1/2 signaling,
while playing a role in the adaptive increase in ACTH-stimulated cortisol production in
the LTH adrenal cortex, does so through a pathway not involving MEK/ERK1/2
mediated phosphorylation of eNOS.
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Results from the MEK/ERK1/2 experiment also demonstrated the divergent
effects of ACTH on cortisol and peNOS in LTH FACs; ACTH increased cortisol while
decreasing peNOS which supports our hypothesis that eNOS is involved in the fetal
adaptation to LTH and that regulation of eNOS phosphorylation alters NO production,
which then affects cortisol biosynthesis in LTH FACs. These results show that while
inhibition of the MEK/ERK1/2 pathway with UO was able to prevent the increase in
cortisol in cells stimulated with ACTH, it had no effect on peNOS suggesting that UO
works through a different mechanism to inhibit cortisol production.
Inhibition of steroidogenesis by UO has been shown in both granulosa (9) and
Leydig (25, 38) cells. These studies demonstrated that although stimulated synthesis of
steroid was inhibited by UO, when cells were stimulated with 22R-hydroxycholesterol
(22R-OHC), a membrane permeable form of cholesterol, steroid production was
unaffected. This suggests UO was blocking steroidogenesis by preventing cholesterol
translocation into the mitochondria, a process carried out by steroidogenic acute
regulatory (StAR) protein. StAR, classically regulated by PKA via cAMP (39), is
responsible for transporting cholesterol to the inner mitochondrial membrane for
conversion from cholesterol to pregnenolone by CYP11A1 (P450scc) (8, 21, 24, 40, 41),
the rate-limiting step for cortisol biosynthesis. Inhibition of StAR activity would halt
steroidogenesis by eliminating the substrate. In this study, we stimulated FACs with 22ROHC, a substrate that does not require transport, to examine the effects of UO on
cholesterol translocation. We found that UO blocked the cortisol increase observed in
cells stimulated with ACTH and water-soluble cholesterol (WSC), which both require
cholesterol transport across the membrane, however UO had no effect on the 22R-OHC
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stimulated increase. Together this suggests that UO may be able to block cholesterol
transport to limit cortisol production and demonstrates that an adaptation does occur in
response to LTH to allow for increased cortisol in response to a secondary stressor.
Although it is evident from our prior studies that eNOS is involved in the fetal
adaptation to LTH and that ACTH stimulation decreases peNOS while increasing
cortisol, our finding in the present study that inhibition of MEK/ERK1/2 did not have an
effect on peNOS suggests that another pathway may play a role in the phosphorylation
state of peNOS. Inhibition of the PI3K/Akt pathway has been implicated in inhibition of
stimulated steroid production in multiple steroidogenic cell types (22, 37) and has also
been shown to reduce eNOS phosphorylation in endothelial cells followed by decreased
NO production (14, 17, 28). We examined the role of the PI3K/Akt pathway by
stimulating FACs with ACTH, with and without pretreatment with PI3K/Akt pathway
inhibitor WT, and examined cortisol and eNOS protein expression and phosphorylation
in both normoxic and LTH groups. Pretreatment with WT had no effect alone but
enhanced ACTH-stimulated cortisol synthesis above ACTH alone. This suggests that the
PI3K/Akt pathway differentially regulates cortisol biosynthesis in LTH FACs and may
work to prevent even higher levels of cortisol in LTH FACs under stimulated conditions.
We also found that PI3K/Akt inhibition did not affect eNOS expression in either
normoxic or LTH FACs and had no effect on peNOS in normoxic FACs. However, WT,
and ACTH as we had previously seen, significantly reduced peNOS in LTH FACs,
suggesting the involvement of the PI3K/Akt pathway in the fetal adaptation to LTH;
PI3K/Akt inhibition with WT reduced peNOS and allowed for an even greater increase in
cortisol in ACTH-stimulated LTH FACs. This further supports the idea that

68

phosphorylation of eNOS is closely linked to cortisol synthesis in the LTH fetus while
other mechanisms play a more dominant role in normoxic adrenals. It also suggests that
while ACTH stimulates cortisol biosynthesis in both normoxic and LTH FACs, it may
also interact with the PI3K/Akt pathway in LTH FACs resulting in the observed
enhanced cortisol production.
A possible intermediary between ACTH and eNOS is protein phosphatase 2A
(PP2A). PP2A has been shown to be capable of dephosphorylating eNOS and the
inhibition of PP2A increases peNOS in endothelial cells (16, 27), however the effects of
LTH on this system are unexplored. Preliminary data from our lab shows significantly
greater PP2A expression in the LTH adrenal cortex compared to normoxic tissue
(unpublished results) suggesting the involvement of PP2A in the fetal adaptation to LTH.
If ACTH increases PP2A activity, combined with greater PP2A expression, it would
reduce peNOS, thereby reducing NO production and effectively limiting the inhibition of
NO on cortisol production in LTH FACs.
Taken together, the results from the present studies as well as our previous work
(31, 32, 42, 43) indicate that LTH has profound adaptive effects on the fetal adrenal
cortex. NO, produced by eNOS, may play an important role in this adaptation in the LTH
fetus. The results from this study show that while the MEK/ERK pathway is involved in
cortisol biosynthesis, as evidenced by UO inhibition of cholesterol transport in response
to ACTH stimulation, it is not involved in the differential regulation of eNOS
phosphorylation. These results also show that both the PI3K/Akt pathway and ACTH
differentially regulate peNOS. Collectively, these data suggest that the PI3k/Akt pathway
and ACTH regulation of eNOS phosphorylation in LTH fetal adrenal cortical cells may
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be key components of the fetal adaptation in cortisol biosynthesis. Combined with the
higher levels of eNOS protein in the LTH adrenals, the PI3K/Akt pathway and ACTH
may work congruently in LTH FACs to regulate eNOS activity via phosphorylation; the
PI3K/Akt pathway maintains peNOS to allow NO to be produced while ACTH
stimulation overrides the PI3K/Akt pathway to reduce peNOS and limit NO production.
Together, these mechanisms would preserve normal cortisol levels under basal conditions
but also allow for the robust increase in cortisol observed in stimulated LTH FACs when
compared to normoxic controls.
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CHAPTER THREE
EFFECTS OF 8BROMO-CAMP AND UO126 ON CORTISOL BIOSYNTHESIS
AND ENOS PHOSPHORYLATION IN OVINE LONG-TERM HYPOXIC FETAL
ADRENOCORTICAL CELLS

Abstract
Previously we have demonstrated enhanced cortisol biosynthesis in long-term
hypoxic (LTH) fetal adrenocortical cells (FACs) in response to stress levels of ACTH
that was not a result of differences in cyclic 3,5-adenosine mono phosphate (cAMP) or
protein kinase A (PKA). We did show that inhibition of the MEK/ERK1/2 pathway with
UO126 (UO) was able to prevent increased cortisol in both normoxic and LTH FACs but
the mechanism was unknown. This study was designed to determine the role of cAMP
stimulation, using the analog 8Bromo-cAMP (8Br), and MEK/ERK1/2 pathway
inhibition on cortisol production and eNOS phosphorylation (peNOS) in the ovine fetal
adrenal in response to long term hypoxia (LTH). Pregnant ewes were maintained at high
altitude (3820m) for approximately the last 100 days of gestation (dGa). At 138-142 dGa,
fetal adrenal cortical cells (FACs) were collected from LTH and age matched normoxic
ovine fetuses. Cortisol production and peNOS were measured in response to 8Br
stimulation and pretreatment with MEK/ERK1/2 pathway inhibitor UO. Neither 8Br nor
UO affected peNOS but UO reduced 8Br-stimulated cortisol in normoxic and LTH FACs
suggesting that cAMP and the MEK/ERK1/2 pathway are not involved in regulating
eNOS phosphorylation in the LTH ovine fetal adrenal.
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Introduction
The study presented in this chapter on the effects of 8Bromo-cAMP (8Br)
stimulation and MEK/ERK1/2 inhibition with UO126 (UO) on cortisol biosynthesis and
eNOS phosphorylation in ovine long-term hypoxic (LTH) fetal adrenocortical cells
(FACs) was conducted as an adjunct to the studies presented in the previous published
chapter.
The fetus has the ability to adapt the hypothalamic-pituitary-adrenal (HPA) axis
to the chronic stress of long-term moderate gestational hypoxia (LTH). In response to
conditions of LTH, the fetus maintains normal basal plasma cortisol concentrations,
despite elevated levels of adrenocorticotropic hormone (ACTH) (17). However, unlike
basal conditions, the LTH fetus has a heightened cortisol response to acute secondary
stressors compared to normoxic fetuses (1, 11). While we found no differences in cyclic
adenosine monophosphate (cAMP) production or protein kinase A (PKA) activation
basally or in response to ACTH in LTH fetal adrenocortical cells (FACs) (23), CYP11A1
and CYP17, two key steroidogenic P450 enzymes, and ACTH receptor (ACTH-R) were
decreased (18). These changes may contribute to the ability of the LTH fetus to maintain
basal cortisol levels despite elevated ACTH, however the mechanism of regulation that
allows the fetus to overcome this suppression with enhanced cortisol production in
response to a secondary stress is still undefined.
In our previous studies, we found that inhibition of the MEK/ERK1/2 signaling
pathway with UO126 reduced ACTH-induced cortisol production in both normoxic and
LTH FACs (24), and that MEK/ERK1/2 signaling does not affect cortisol through
regulation of eNOS phosphorylation; inhibition with UO126 did not alter peNOS in
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either normoxic or LTH FACs and did not differentially limit ACTH-stimulated cortisol
production between normoxic and LTH FACs (19). Together these results suggest that
the MEK/ERK1/2 pathway affects cortisol production and acts through a mechanism
other than NO to impact cortisol steroidogenesis. Classically, ACTH-stimulated cortisol
biosynthesis is regulated via 3,5-cAMP/PKA activation of steroidogenic acute regulatory
(StAR) protein (7, 21). We found that enhanced ACTH-stimulated cortisol production in
LTH FACs is not a result of increased cAMP production and/or PKA activation,
however, expression of StAR protein, responsible for cholesterol transport in to the inner
mitochondrial membrane for the initial rate limiting step in steroidogenesis, was
increased in LTH FACs compared to normoxic controls (23). These results indicate that
while MEK/ERK1/2 signaling is involved in cortisol biosynthesis, the adaptive
mechanism dissociating cortisol production from elevated ACTH lies downstream from
ACTH signal transduction. This study was designed to (1) assess whether activation of
steroidogenesis via membrane permeable cAMP analog 8Bromo-cAMP (8Br) is altered
by MEK/ERK1/2 pathway inhibition with UO, and (2) determine whether 8Br activation
of steroidogenesis regulates eNOS phosphorylation in FACs.

Materials and Methods
Animals
Time-dated pregnant ewes were maintained at the Barcroft Laboratory White
Mountain Research Station (3820m, maternal PO2 ~ 60mmHg) from approximately 40
days gestational age (dGa) to near term (term ≅ 146 days). Following transportation to
the laboratory, hypoxia was maintained by nitrogen infusion through a maternal tracheal
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catheter as previously described (1, 9, 11, 15, 19, 23). Age-matched, normoxic ewes
served as controls. On 138 to 142 dGa, ewes were sedated and maintained under general
anesthesia while fetuses were delivered through midline laparotomy. Procedures were
performed as previously described in detail (13). Fetal adrenal glands were collected in
ice-cold media M-199 (Sigma-Aldrich, St. Louis, Missouri), containing 2.2 g sodium
bicarbonate, 2.0 g bovine serum albumin, and 0.1 g L-glutamine for cell dispersion and
subsequent study. All procedures were conducted with the approval of the Institutional
Animal Care and Use Committees (Loma Linda University School of Medicine, Loma
Linda, CA).

Cell Dispersion
Procedures for collection of FACs were similar to those we described previously
(19, 23, 24). Briefly, fetal adrenal glands were divided in half along the longitudinal axis
and the cortex was separated from the medulla. The cortical tissue was minced and
enzymatically dispersed with 40 mg collagenase Type II (Worthington Biomedical,
Lakewood, NJ), 40 mg of Polypep bovine protein digest (Sigma-Aldrich) and 100 µl of
DNAse I (Type IV; Sigma-Aldrich) dissolved in 10 mL of Sodium Krebs Buffer (0.4%
collagenase). The resulting monodispersed FACs were aliquoted into individual tubes
with media (M-199), and allowed to equilibrate for 2 hr at 37°C prior to initiation of the
study as required by the experimental protocol. Cell viability was confirmed by Trypan
blue exclusion.
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Treatment Protocol
Effects of MEK/ERK1/2 inhibition and 8Bromo-cAMP stimulation on cortisol
biosynthesis and eNOS phosphorylation
FACs, aliquoted at 7.5x105 cells/mL, were untreated, pretreated with
MEK/ERK1/2 inhibitor UO126 (UO, 10 µM) for 1 hour, or stimulated with 8BromocAMP (8Br, 10 mM), with and without UO pretreatment. Media and cells were collected
at 0 (baseline), 10, 20, and 60 minutes after stimulation (Figure 1). Media were
immediately frozen in liquid nitrogen, and stored at -80°C until determination of cortisol.
Cells were lysed in 80 µL of lysis buffer (93% prelysis buffer [1 mmol/L Trizma Base,
10 mmol/L NaCl, 0.1 mmol/L EDTA, 0.1 mmol/L EGTA, 1% Triton X-100, 0.5% Igepal
CO-630, 20 mmol/L NaF], 1% 100 mmol/L phenylmethanesulfonyl fluoride, 1%
Protease Inhibitor Cocktail [Sigma, St Louis, Missouri], 5% 20 mmol/L sodium
orthovanadate), frozen in liquid nitrogen, and stored at -80°C until analysis.

8Br 10 mM

UO 10 µM

Rest 2hr

Pretreat 1hr
0min

20min
10min

60min

Figure 1. Timeline for treatment protocol 8Bromo-cAMP. UO, UO126; 8Br, 8BromocAMP.
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Cortisol Assay
Cortisol was measured using a commercially available enzyme-linked
immunosorbent assay cortisol kit (Oxford Biomedical Research, Oxford, Michigan) that
has been previously described and validated for use in our laboratory (10, 15, 18).

Western Analysis
Endothelial NOS protein was analyzed from FACs collected at 0 (baseline), 10,
20, and 60 min for both normoxic and LTH groups, described earlier. Samples were
thawed and protein concentration was determined using a bicinchoninic acid protein
assay (Thermo Scientific, Rockford, Illinois) with BSA as the standard. Absorbance was
measured at 595 nm on a BioTek Synergy HT Multi-Mode Microplate Reader
(Winooski, Vermont).
Endothelial NOS protein phosphorylation was determined by Western blotting
using methods we have previously described and validated (17, 18). Briefly, protein
samples were denatured for 5 minutes at boiling temperature and a total of 20 µg of
protein were loaded per lane. Protein samples were separated using 7.5% polyacrylamide
gels (Bio-Rad, Hercules, California) and subjected to electrophoresis (sodium dodecyl
sulfate polyacrylamide gel electrophoresis) and then transferred to polyvinylidene
fluoride membranes (Millipore, Billerica, Massachusetts) using a Transblot cell apparatus
(Bio-Rad).
To determine the level of eNOS protein phosphorylation, the membranes were
incubated with a rabbit monoclonal phospho-eNOS (Ser1177; C9C3) primary antibody
(Cell Signaling, Product#9570) in 10 mL 5% BSA Tris-buffered saline with Tween 20
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(TBST) solution (1:1000) overnight at 4°C. Membranes were then incubated with goat
anti-rabbit polyclonal secondary antibody (ThermoScientific, Product#35571) in 10 mL
5% BSA TBST solution (1:10000) for 90 minutes, washed, and imaged with a Licor
Odyssey Infrared Imaging System (LI-COR Bio-sciences, Lincoln, Nebraska) at 700 nm.
The relative optical densities (ROD) of the bands were used to measure normoxic and
LTH phosphorylated eNOS (peNOS) protein expression. An internal positive standard
prepared from whole fetal adrenal tissue was used to normalize peNOS protein.
To determine the level of eNOS protein expression, the membranes were first
stripped of phosphorylated antibody and incubated with mouse anti-eNOS primary
antibody (BD Transduction, Product# 610296) in 10 mL 5% nonfat dry milk (NFDM)
TBST solution (1:250) overnight at 4°C. Membranes were then incubated with goat antimouse polyclonal secondary antibody (Thermo Scientific, Product# 35518) in 10 mL 5%
NFDM TBST solution (1:20000) for 90 minutes, washed, and imaged with a Licor
Odyssey Infrared Imaging System (LI-COR Bio-sciences, Lincoln, Nebraska) at 800 nm.
The RODs of the bands were used to measure normoxic and LTH eNOS protein
expression. An internal positive standard prepared from whole fetal adrenal tissue was
used to normalize eNOS protein as we have previously described in our laboratory (14,
24).

Statistical Analysis
Descriptive statistics are presented as mean ± standard error. Data analysis was
performed using two-way analysis of variance (ANOVA) with 1 between-subject factor
(treatment) and 1 within-subject factor (time) stratified by oxygenation level (normoxic
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or LTH). The main effect tested was in vitro treatment (UO). Alpha was set at .05
significance level. Post hoc tests were adjusted using the Bonferroni method. Statistical
analyses were performed GraphPad Prism 5 (Version 5.04; GraphPad Software, Inc.,
2010).

Results
Effects of MEK/ERK1/2 Inhibition and 8Bromo-cAMP Stimulation
Cortisol Production
There were no differences observed in cortisol production from either normoxic
(n=6) or LTH (n=6) FACs that were pretreated with UO compared to the untreated cells,
and cortisol levels remained relatively constant throughout the 60 minutes of study
(Figure 2). There was a significant increase in cortisol output from both normoxic and
LTH FACs; in control normoxic FACs, cortisol was significantly elevated by 60 minutes
after 8Br stimulation (p<0.05) compared to time 0, while a significant increase in cortisol
output was observed in LTH FACs in response to 8Br by 10 minutes compared to time 0.
The maximal increase in cortisol production was approximately 15 fold in the LTH FACs
compared to approximately 5 fold in the control cells. Pretreatment with UO inhibited the
8Br-stimulated increase in cortisol in both normoxic and LTH FACs compared to 8Br
alone (p<0.05).

Expression of eNOS
Treatment with 8Br and UO pretreatment had no effect on expression of eNOS
protein in either normoxic or LTH FACs compared to control (Figure 3A).
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Phosphorylation of eNOS
Treatment with 8Br and UO pretreatment had no effect on phosphorylation of
eNOS protein in either normoxic or LTH FACs compared to control (Figure 3B).
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Figure 2. Time course of cortisol production in normoxic and LTH FACs with
MEK/ERK1/2 inhibition and 8Bromo-cAMP stimulation. Treatment with 8Br (10mM)
increased cortisol production in both normoxic and LTH FACs. UO126 (10µM)
pretreatment had no effect on basal cortisol, but prevented increased cortisol biosynthesis
in response to 8Br stimulation in both normoxic and LTH. (Normoxic n=6, LTH n=6)
Values represent mean values ± SEM. *p<0.05 compared to time 0. FACs, fetal
adrenocortical cells; LTH, long-term hypoxia; UO, UO126; 8Br, 8Bromo-cAMP.
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Figure 3. Protein expression (A) and phosphorylation (B) of eNOS in response to
MEK/ERK1/2 inhibition and 8Bromo-cAMP stimulation in normoxic and LTH FACs as
determined by Western analysis. Pretreatment with UO (10µM) with and without 8Br
(10mM) stimulation had no effect on either eNOS or peNOS in both normoxic and LTH
FACs compared to control. (Normoxic n=6, LTH n=6) Values represent mean values ±
SEM. FACs, fetal adrenocortical cells; LTH, long-term hypoxia; eNOS, endothelial nitric
oxide synthase; peNOS, phosphorylated endothelial nitric oxide synthase; ROD, relative
optical density; UO, UO126; 8Br, 8Bromo-cAMP.
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Discussion
Cortisol regulation is a critical component of fetal development due to its
involvement tissue growth and maturation; chronically high levels of glucocorticoids can
suppress normal anabolic processes necessary for fetal growth (3, 12, 16). In the LTH
ovine fetus, there is an adaptive response of the HPA axis to upregulate the
hypothalamic-anterior pituitary portion with increased release of CRH and AVP (10), as
well as elevated basal plasma ACTH and enhanced processing of POMC to ACTH (17).
In contrast, expression of key steroidogenic enzymes (CYP11A1 and CYP17) as well as
expression of ACTH receptor mRNA are reduced (18), and basal adrenal cortisol levels
remain normal, despite elevated ACTH (1, 8, 11, 17). And in response to a secondary
stressor, the LTH fetus produces enhanced levels of cortisol compared to the normoxic
fetus (1, 11). Enhanced cortisol secretion in LTH FACs was not the result of increased
cAMP production and/or protein kinas A (PKA) stimulation, however expression of
steroidogenic acute regulatory protein was greater in LTH compared to normoxic FACs
(23). Together, this suggests an adaptation in the HPA axis that maintains normal basal
levels of cortisol required for fetal development, but allows for enhanced cortisol
production in response to a secondary stress.
Cortisol production in the adrenal cortex is classically known to be regulated by
signaling of ACTH via 3,5-cAMP, which activates PKA liberation of cholesterol and
activation of StAR, and StAR transfers cholesterol to the inner mitochondrial membrane
for conversion into pregnenolone by CYP11A1, a major rate limiting step cortisol
biosynthesis (2, 7, 20-22). In a previous study, we also showed that cortisol production
can be regulated by nitric oxide (NO); NO inhibited ACTH-stimulated cortisol
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production and endothelial nitric oxide synthase (eNOS) inhibition enhanced cortisol
synthesis in LTH ovine FACs (15). Further, we demonstrated that LTH enhanced eNOS
expression (14) and NOS activity in LTH compared to normoxic adrenals (15). We more
recently found that MEK/ERK1/2 inhibition with UO126 (UO) reduced ACTHstimulated cortisol production in both normoxic and LTH FACs (19, 24), but had no
effect on eNOS phosphorylation (peNOS) (19). Unlike UO, stimulation of cortisol
production with ACTH reduced peNOS in LTH FACs and enhanced cortisol production
above normoxic levels (19).
In the present study, we examined the effects of UO inhibition on 8Bromo-cAMP
(8Br) stimulated cortisol production and 8Br stimulation on peNOS to determine the
involvement of cAMP in the fetal adaptation to LTH. 8Br is a cAMP analog that does not
require a membrane receptor; it diffuses through the membrane to activate PKA and
stimulate cortisol production. In rat adrenal zona fasiculata cells, 8Br was shown to
increase corticosterone biosynthesis (5, 6), and treatment of Y1 mouse adrenocortical
cells with 8Br increased StAR protein and mRNA in a PKA-dependent manner (4). In
our FACs, we found that, similar to ACTH in chapter 2, 8Br enhanced cortisol
production in both normoxic and LTH FACs, consistent with cAMP/PKA pathway
regulation, with LTH levels greater than those achieved in normoxic FACs. Also similar
to the previous study, UO reduced cortisol output in response to 8Br stimulation in both
normoxic and LTH FACs, indicating that UO inhibition of cortisol synthesis is
downstream of cAMP/PKA signaling. Unlike ACTH, however, 8Br-stimulated cortisol
production did not elicit as great of an enhancement in LTH FACs, possibly due to the
time required to reach stimulatory intracellular concentrations, and 8Br had no effect on
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peNOS in both normoxic and LTH FACs, suggesting that ACTH dephosphorylation is
not cAMP dependent and that ACTH regulates acute cortisol production through
alternative signaling mechanisms activated by LTH that induce phosphatase activity.
Taken together, the results from the present study as well as our previous work
(14, 15, 23, 24) indicate that LTH has profound adaptive effects on the fetal adrenal
cortex; activation of the cAMP/PKA pathway enhances cortisol production in ovine LTH
FACs. The results from this study show that while the MEK/ERK1/2 pathway and cAMP
are involved in cortisol biosynthesis, as evidenced by UO inhibition and 8Bromo-cAMP
stimulation of cortisol production, they are not involved in the differential regulation of
eNOS phosphorylation. 8Br had similar effects as ACTH and in response to UO on
cortisol in LTH and normoxic FACs, supporting the role of cAMP in cortisol synthesis in
FACs, but UO inhibition seems to be downstream of cAMP, as 8Br stimulation was able
to enhance cortisol synthesis but UO effectively limited cortisol production in both
normoxic and LTH FACs. However, 8Br had no effect on peNOS, indicating the
activation of alternative mechanisms by ACTH to induce phosphatase activity. Although
8Br stimulation did enhance cortisol in LTH FACs to levels above those observed in the
normoxic FACs, the use of this analog was not able to replicate the results of ACTHstimulated reduction in peNOS. This suggests that this cAMP analog does not effectively
replicate the actions of the native cAMP, or that ACTH activates an alternative
mechanism outside of the classical cAMP/PKA signaling pathway to affect both cortisol
and eNOS phosphorylation.
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CHAPTER FOUR
EFFECTS OF A23187 AND ACTH ON CORTISOL BIOSYNTHESIS AND ENOS
PHOSPHORYLATION IN OVINE LONG-TERM HYPOXIC FETAL
ADRENOCORTICAL CELLS

Abstract
In the long-term hypoxic (LTH) fetus, we have shown that cortisol production is
enhanced in response to secondary stress, while basal levels remain normal despite
elevated basal ACTH. Nitric oxide (NO) may be a major regulator of this mechanism as
we have shown that NO inhibits cortisol production in LTH fetal adrenocortical cells
(FACs). We have also shown that endothelial nitric oxide synthase (eNOS) expression is
greater in the LTH fetal adrenal, and that NOS activity is reduced by ACTH treatment in
LTH FACs. This study was designed to determine the role of calcium signaling on eNOS
phosphorylation (peNOS) and subsequent cortisol production in the ovine FACs in
response to long term hypoxia (LTH). Pregnant ewes were maintained at high altitude
(3820m) for approximately the last 100 days of gestation (dGa). At 138-142 dGa, fetal
adrenal cortical cells (FACs) were collected from LTH and age matched normoxic ovine
fetuses. Cortisol production and peNOS were measured in response to pretreatment with
calcium ionophore A23187 and ACTH stimulation. A23187 had no effect on cortisol
production or peNOS in both normoxic and LTH FACs, suggesting that calcium
signaling does not play a major role in regulating cortisol or eNOS phosphorylation in the
ovine fetal adrenal.
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Introduction
Long-term hypoxia (LTH) in the fetus causes adaptations that lead to increased
basal plasma concentrations of ACTH, however cortisol levels remain normal under basal
conditions (37). In response to a secondary stress, cortisol production is enhanced in the
LTH fetus beyond levels achieved in the normoxic (3, 24), suggesting a mechanism of
cortisol regulation that maintains normal cortisol levels under basal conditions but allows
for a heightened output in response to stress. The mechanism for this adaptation may be
mediated by nitric oxide (NO) produced from endothelial nitric oxide synthase (NOS).
Previous work from our lab has shown that eNOS expression was greater in LTH
fetal adrenals (34), and that NO inhibited ACTH-stimulated cortisol production while
NOS inhibition enhanced cortisol synthesis in LTH FACs (35). This suggests that eNOS
and subsequent NO production plays an important role in regulating cortisol biosynthesis
in response to a secondary stress in the fetus.
The regulation of eNOS activity has been shown to occur through posttranslational mechanisms including phosphorylation (13), protein-protein interactions
with caveolin-1 (Cav-1) and heat shock protein 90 (Hsp90) (7, 8, 22), and interaction
with calcium (Ca2+)/calmodulin (CaM) (31). Calmodulin is an allosteric activator of
eNOS and increases in intracellular Ca2+ concentrations promote the dissociation of
eNOS with the inhibitory protein Cav-1 and association of eNOS with CaM (27, 29, 39,
45). The activated eNOS-CaM complex synthesizes NO until Ca2+ decreases and CaM
dissociates, followed by reformation of the eNOS-Cav-1 complex (1, 25, 27, 30, 40).
This mechanism of Ca2+ regulation of eNOS has been well characterized in
endothelial cells, but not as well explored in steroidogenic cells, especially the fetal
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adrenal, and studies on the effects of Ca2+ on eNOS phosphorylation (peNOS) are
limited. Further, the role of Ca2+ regulation of peNOS under hypoxic conditions is
uncertain. In endothelial cells, treatment with calcium ionophore A23187 increased
peNOS and NO production (4, 23, 51), while Ca2+ chelators and calcium free media
prevented stimulated increases in peNOS (15, 21). Taken together, these studies suggest
that Ca2+ plays an important role in regulating peNOS. This study was designed to
examine the effects of elevating intracellular calcium with calcium ionophore A23187 on
peNOS and subsequent cortisol biosynthesis to determine the role of calcium in
regulating fetal eNOS and cortisol production in LTH ovine FACs.

Materials and Methods
Animals
Time-dated pregnant ewes were maintained at the Barcroft Laboratory White
Mountain Research Station (3820m, maternal PO2 ~ 60mmHg) from approximately 40
dGa to near term (term ≅ 146 days). Following transportation to the laboratory, hypoxia
was maintained by nitrogen infusion through a maternal tracheal catheter as previously
described (3, 11, 24, 35, 41, 49). Age-matched, normoxic ewes served as controls. On
138 to 142 dGa, ewes were sedated and maintained under general anesthesia while
fetuses were delivered through midline laparotomy. Procedures were performed as
previously described in detail (33). Fetal adrenal glands were collected in ice-cold media
M-199 (Sigma-Aldrich, St. Louis, Missouri), containing 2.2 g sodium bicarbonate, 2.0 g
bovine serum albumin, and 0.1 g L-glutamine for cell dispersion and subsequent study.
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All procedures were conducted with the approval of the Institutional Animal Care and
Use Committees (Loma Linda University School of Medicine, Loma Linda, CA).

Cell Dispersion
Procedures for collection of FACs were similar to those we described previously
(41, 49, 50). Briefly, fetal adrenal glands were divided in half along the longitudinal axis
and the cortex was separated from the medulla. The cortical tissue was minced and
enzymatically dispersed with 40 mg collagenase Type II (Worthington Biomedical,
Lakewood, NJ), 40 mg of Polypep bovine protein digest (Sigma-Aldrich) and 100 µl of
DNAse I (Type IV; Sigma-Aldrich) dissolved in 10 mL of Sodium Krebs Buffer (0.4%
collagenase). The resulting monodispersed FACs were aliquoted into individual tubes
with media (M-199), and allowed to equilibrate for 2 hr at 37°C prior to initiation of the
study as required by the experimental protocol. Cell viability was confirmed by Trypan
blue exclusion.

Treatment Protocol
Effects of A23187 treatment and ACTH stimulation on eNOS phosphorylation and
cortisol biosynthesis
FACs, aliquoted at 7.5x105 cells/mL, were untreated, pretreated with calcium
ionophore A23187 (3.3 µM) for 1 hour, or stimulated with ACTH (100 pM), with and
without A23187 pretreatment. Media and cells were collected at 0 (baseline), 10, 20, and
60 minutes after stimulation. Media were immediately frozen in liquid nitrogen, and
stored at -80°C until determination of cortisol. Cells were lysed in 80 µL of lysis buffer

96

(93% prelysis buffer [1 mmol/L Trizma Base, 10 mmol/L NaCl, 0.1 mmol/L EDTA, 0.1
mmol/L EGTA, 1% Triton X-100, 0.5% Igepal CO-630, 20 mmol/L NaF], 1% 100
mmol/L phenylmethanesulfonyl fluoride, 1% Protease Inhibitor Cocktail [Sigma, St
Louis, Missouri], 5% 20 mmol/L sodium orthovanadate), frozen in liquid nitrogen, and
stored at -80°C until analysis.

ACTH 100 pM

A23187 3.3 µM

Rest 2hr

Pretreat 1hr
0min

20min
10min

60min

Figure 1. Timeline for treatment protocol A23187. ACTH, adrenocorticotropic hormone;
A23187, calcium ionophore A23187.

Cortisol Assay
Cortisol was measured using a commercially available enzyme-linked
immunosorbent assay cortisol kit (Oxford Biomedical Research, Oxford, Michigan) that
has been previously described and validated for use in our laboratory (12, 35, 38).

Western Analysis
Endothelial NOS protein was analyzed from FACs collected at 0 (baseline), 10,
20, and 60 min for both normoxic and LTH groups, described earlier. Samples were
thawed and protein concentration was determined using a bicinchoninic acid protein
assay (Thermo Scientific, Rockford, Illinois) with BSA as the standard. Absorbance was
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measured at 595 nm on a BioTek Synergy HT Multi-Mode Microplate Reader
(Winooski, Vermont).
Endothelial NOS protein expression and phosphorylation was determined by
Western blotting using methods we have previously described and validated (37, 38).
Briefly, protein samples were denatured for 5 minutes at boiling temperature and a total
of 20 µg of protein were loaded per lane. Protein samples were separated using 7.5%
polyacrylamide gels (Bio-Rad, Hercules, California) and subjected to electrophoresis
(sodium dodecyl sulfate polyacrylamide gel electrophoresis) and then transferred to
polyvinylidene fluoride membranes (Millipore, Billerica, Massachusetts) using a
Transblot cell apparatus (Bio-Rad).
To determine the level of eNOS phosphorylation, the membranes were incubated
with a rabbit monoclonal phospho-eNOS (Ser1177; C9C3) primary antibody (Cell
Signaling, Product#9570) in 10 mL 5% BSA Tris-buffered saline with Tween 20 (TBST)
solution (1:1000) overnight at 4°C. Membranes were then incubated with goat anti-rabbit
polyclonal secondary antibody (ThermoScientific, Product#35571) in 10 mL 5% BSA
TBST solution (1:10000) for 90 minutes, washed, and imaged with a Licor Odyssey
Infrared Imaging System (LI-COR Bio-sciences, Lincoln, Nebraska) at 700 nm. The
relative optical densities (ROD) of the bands were used to measure normoxic and LTH
phosphorylated eNOS (peNOS) protein expression. An internal positive standard
prepared from whole fetal adrenal tissue was used to normalize peNOS protein.
To determine the level of eNOS protein expression, the membranes were first
stripped of phosphorylated antibody and incubated with mouse anti-eNOS primary
antibody (BD Transduction, Product# 610296) in 10 mL 5% nonfat dry milk (NFDM)
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TBST solution (1:250) overnight at 4°C. Membranes were then incubated with goat antimouse polyclonal secondary antibody (Thermo Scientific, Product# 35518) in 10 mL 5%
NFDM TBST solution (1:20000) for 90 minutes, washed, and imaged with a Licor
Odyssey Infrared Imaging System (LI-COR Bio-sciences, Lincoln, Nebraska) at 800 nm.
The RODs of the bands were used to measure normoxic and LTH eNOS protein
expression. An internal positive standard prepared from whole fetal adrenal tissue was
used to normalize eNOS protein as we have previously described in our laboratory (34,
50).

Statistical Analysis
Descriptive statistics are presented as mean ± standard error. Data analysis was
performed using two-way analysis of variance (ANOVA) with 1 between-subject factor
(treatment) and 1 within-subject factor (time) stratified by oxygenation level (normoxic
or LTH). The main effect tested was in vitro treatment (A23187). Alpha was set at .05
significance level. Post hoc tests were adjusted using the Bonferroni method. Statistical
analyses were performed GraphPad Prism 5 (Version 5.04; GraphPad Software, Inc.,
2010).

Results
Effects of A23187 and ACTH Stimulation
Cortisol Production
ACTH significantly increased cortisol production in both normoxic and LTH
FACs. A23187 did not affect cortisol output in both normoxic and LTH FACs, with and
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without ACTH stimulation (Figure 2).

Expression of eNOS
Treatment with A23187 and ACTH had no effect on expression of eNOS protein
in either normoxic or LTH FACs compared to control (Figure 3A).

Phosphorylation of eNOS
Treatment with A23187 and ACTH had no effect on phosphorylation of eNOS
protein in either normoxic or LTH FACs compared to control (Figure 3B).
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Figure 2. Time course of cortisol production in normoxic and LTH FACs with calcium
ionophore A23187 pretreatment and ACTH stimulation. Treatment with ACTH (100pM)
increased cortisol production in both normoxic and LTH FACs. A23187 (3.3µM)
pretreatment had no effect on basal or ACTH-induced cortisol biosynthesis in both
normoxic and LTH. (Normoxic n=5, LTH n=5) Values represent mean values ± SEM.
*p<0.05 compared to time 0. FACs, fetal adrenocortical cells; LTH, long-term hypoxia;
ACTH, adrenocorticotropic hormone; A23187, calcium ionophore A23187.
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Figure 3. Protein expression (A) and phosphorylation (B) of eNOS in response to calcium
ionophore A23187 and ACTH stimulation in normoxic and LTH FACs as determined by
Western analysis. Pretreatment with A23187 (3.3µM) with and without ACTH (100pM)
stimulation had no effect on eNOS or peNOS in both normoxic and LTH FACs compared
to control. (Normoxic n=5, LTH n=5) Values represent mean values ± SEM. FACs, fetal
adrenocortical cells; LTH, long-term hypoxia; eNOS, endothelial nitric oxide synthase;
peNOS, phosphorylated endothelial nitric oxide synthase; ROD, relative optical density;
ACTH, adrenocorticotropic hormone; A23187, calcium ionophore A23187.
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Discussion
The regulation of cortisol biosynthesis in the fetus is critical due to its
involvement in growth and maturation, and chronically high levels can suppress the
normal processes necessary for development (6, 28, 36). The hypothalamic-pituitaryadrenal (HPA) axis of the long-term hypoxic (LTH) fetus undergoes significant
adaptation resulting in maintenance of basal levels of cortisol, despite elevated ACTH
(37), and enhanced cortisol biosynthesis in response to a secondary stress (3, 24). This
adaptation may be mediated by nitric oxide (NO) produced by endothelial nitric oxide
synthase (eNOS); we have shown that eNOS expression was greater in LTH fetal
adrenals (34), and that NO inhibited ACTH-stimulated cortisol production while NOS
inhibition enhanced cortisol synthesis in LTH fetal adrenocortical cells (FACs) (35).
Therefore, eNOS regulation of NO production appears to play a critical role in regulating
cortisol biosynthesis in response to stress in the LTH fetus.
Regulation of eNOS has been shown to occur through post-translational
mechanisms including phosphorylation (9, 10, 13, 17, 18, 32), protein-protein
interactions with caveolin-1 (Cav-1) and heat shock protein 90 (Hsp90) (7, 8, 19, 20, 22),
and interaction with calcium (Ca2+)/calmodulin (CaM) (16, 31). In our lab, we have
shown that although there is significant co-localization of eNOS with regulatory proteins
Hsp90 and Cav-1 present in the fetal adrenal, there were no changes in co-localization of
either protein with eNOS in the LTH fetus compared to normoxic controls (46). This
indicates that Cav-1/Hsp90 regulation of eNOS is likely not an important part of the fetal
adaptation to LTH and suggests that other methods are involved. Calcium is a possible
regulator involved in managing eNOS activity. Increases in intracellular Ca2+
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concentrations ([Ca2+]i) have been shown to activate eNOS by inducing dissociation of
eNOS with Cav-1 and association with CaM, initiating NO production (27, 29, 39, 45).
Decreases in [Ca2+]i were followed by CaM dissociation and reformation of the eNOSCav-1 complex, halting NO synthesis (1, 25, 27, 30, 40), showing that eNOS activity is
dependent on [Ca2+]i.
This mechanism of Ca2+ regulation of eNOS has been well characterized in
endothelial cells (1, 2, 16, 25, 27, 30, 40, 44), but not as well explored in steroidogenic
cells, especially the fetal adrenal, and studies on the effects of Ca2+ on eNOS
phosphorylation (peNOS) are limited. Further, the role of Ca2+ regulation of peNOS
under hypoxic conditions is uncertain. Studies have shown that in bovine aortic
endothelial cells (BAECs) and COS-7 transfected cells, treatment with calcium ionophore
A23187 increased peNOS at Ser1177 and NO production (4, 23), while treatment of
endothelial cells with Ca2+ chelators prevented VEGF-mediated peNOS and NO
synthesis (21). In porcine aortic endothelial cells (PAECs), bradykinin-induced peNOS
was reduced in calcium-free media (15), and treatment with A23187 increased NO in
pregnant ovine uterine arteries, inducing relaxation that was enhanced in hypoxic tissues
compared to normoxic (51). Together these results suggest a possible role for Ca2+
regulation of peNOS that may be affected by LTH.
In this study we investigated the role of intracellular calcium on peNOS and
cortisol production in the LTH ovine FACs. We found that while ACTH increased
cortisol production, as we have previously described (35, 41, 49, 50), pretreatment of
FACs with calcium ionophore A23187 had no effect on eNOS expression and
phosphorylation, and subsequent ACTH-stimulated cortisol production was not affected
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in both normoxic and LTH FACs. This implies that [Ca2+]i does not play a major role in
the fetal adaptation to LTH, and may not contribute to eNOS regulation in the fetal
adrenal.
It has been suggested that eNOS regulation may be tissue specific (14), and thus
the lack of calcium influence in the fetal adrenal may be a result of this specificity in
regulation. It could also be a difference in regulation based on the type of agonist; the
requirement of calcium for NO production has been shown to vary depending on the type
of agonist. A rise in calcium is necessary in response to acetylcholine (43) or vascular
endothelial growth factor (42), however fluid shear stress (26), estrogen (5), and insulin
(48) do not require increases in calcium for NO production. In these cases, it is likely that
CaM is bound, as it is an essential regulator of electron flux required for NO generation
(2), but that it’s affinity is not as affected by calcium concentrations. The negative charge
of the phosphate could permit greater activation of eNOS without changing CaM affinity
at varying calcium levels (10, 17, 32, 47), thus generating NO even at lower
calcium/CaM concentrations. Together these data suggest that the lack of changes in
peNOS and cortisol as a result of calcium ionophore A23187 treatment could be tissue
specific. Calcium may not be a major regulator of eNOS in FACs and thus increases in
intracellular calcium may not have an impact on eNOS activity.
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CHAPTER FIVE
EFFECTS OF NITRIC OXIDE ON CORTISOL BIOSYNTHESIS AND MRNA
ABUNDANCE OF CYP11A1, CYP17, STAR, AND ACTH-R IN OVINE LONGTERM HYPOXIC FETAL ADRENOCORTICAL CELLS

Abstract
We previously showed a decrease in key steroidogenic enzymes CYP11A1 and
CYP17, as well as a decrease in ACTH receptor (ACTH-R) in the ovine fetal adrenal that
may contribute to the ability of the LTH fetus to maintain basal cortisol levels despite
elevated ACTH. We have also shown an increase in steroidogenic acute regulatory
(StAR) protein in LTH fetal adrenocortical cells (FACs) that would allow for an
enhanced response to a secondary stress. And we have shown the ability of NO to inhibit
ACTH-induced cortisol production. This study was designed to determine the role of
nitric oxide (NO), using DETA-NO, an NO donor, and L-NAME, a NOS inhibitor, in
altering steroidogenic capacity by measuring cortisol production and mRNA of
CYP11A1, CYP17, StAR, and ACTH-R. Pregnant ewes were maintained at high altitude
(3820m) for approximately the last 100 days of gestation (dGa). At 138-142 dGa, fetal
adrenal cortical cells (FACs) were collected from LTH and age matched normoxic ovine
fetuses and treated over the course of 96h at 37°C and 5% CO2. Cortisol production and
mRNA were measured in response to DETA-NO, L-NAME, and/or ACTH treatment.
DETA-NO and L-NAME did not alter cortisol or mRNA abundance of CYP11A1,
CYP17, StAR, and ACTH-R with and without ACTH treatment in both normoxic and
LTH FACs. ACTH treatment significantly increased cortisol production in both
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normoxic and LTH FACs, and normoxic cortisol concentrations were greater than LTH.
ACTH increased mRNA abundance in both normoxic and LTH FACs, but was not
affected by DETA-NO or L-NAME treatment. Together these results suggest that ACTH
treatment is able to overcome NO inhibition of steroidogenesis over 96h, and NO does
not affect steroidogenesis at the level of mRNA abundance of key steroidogenic enzymes
CYP11A1 and CYP17 or StAR and ACTH-R in the LTH fetal adrenal.

Introduction
Hypoxia is a common fetal stressor that leads to adaptations in the ovine fetal
adrenal. In response to long-term moderate gestational hypoxia (LTH), the fetus
maintains normal basal plasma cortisol concentrations, despite elevated basal levels of
adrenocorticotropic hormone (ACTH) (45). However, the LTH fetus has an enhanced
cortisol response to acute secondary stressors compared to normoxic fetuses (1, 28). This
suggests an adaptation in the HPA axis that prevents early and excess cortisol production,
but allows for increased cortisol production in response to a secondary stress.
Regulation of cortisol is important for fetal development due to its involvement in
tissue growth and maturation (8, 36, 44), and cortisol biosynthesis is regulated through a
series of enzymatic steps. Steroidogenesis involves the key rate-limiting enzymes
cytochrome P450 side-chain cleavage (CYP11A1) and cytochrome P450 17αhydroxylase (CYP17). Additionally, steroidogenic acute regulatory (StAR) protein and
ACTH receptor (ACTH-R) are other necessary components. ACTH initiates
steroidogenesis through activation of ACTH-R (38). StAR is responsible for cholesterol
transport in to the inner mitochondrial membrane, the initial rate limiting step in
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steroidogenesis, where CYP11A1 converts cholesterol into pregnenolone (3, 9, 37, 38,
52, 61). CYP17 continues cortisol biosynthesis by mediating the 17α-hydroxylation of
pregnenolone to 17α-hydroxypregnenolone and progesterone 17α-hydroxyprogesterone
(25).
Under basal conditions, we have previously shown that despite elevated plasma
ACTH, expression of CYP11A1 and CYP17 and ACTH-R are decreased in the adrenal
gland of the LTH fetus (46), while expression of steroidogenic acute regulatory protein
was greater in LTH compared to normoxic fetal adrenocortical cells (FACs) (68). We
also observed that under acute secondary stress in vivo, cortisol production is greater in
LTH fetuses than normoxic controls (1, 28). This is paralleled by in vitro studies that
demonstrate enhanced cortisol biosynthesis in response to “stress” levels of ACTH in
LTH FACs (69). Taken together, these data suggest that levels of CYP11A1, CYP17, and
ACTH-R are adequate to carry out cortisol biosynthesis in the LTH fetal adrenal, but that
there is an inhibitory mechanism under basal conditions on these biosynthetic proteins
that is overridden to induce enhanced cortisol in response to a secondary stressor.
A possible mediator of biosynthetic activity in the LTH fetal adrenal is nitric
oxide (NO), a diatomic free radical molecule with a variety of physiological functions
and produced from L-arginine by NO synthases (NOSs) (27, 42). NO has clearly been
shown to inhibit CYP expression (17, 59) and activity (11, 13, 23) in adrenal cells.
Studies from our own laboratory showed that NO inhibited ACTH-stimulated cortisol
while NOS inhibition enhanced cortisol output in LTH FACs (41) . Thus, NO appears to
play a role in regulating cortisol biosynthesis in the LTH fetal adrenal.
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This study was designed to address the role of extended NO exposure, via NO
donor DETA-NO, or removal, via NOS inhibitor L-NAME, on CYP11A1, CYP17,
StAR, and ACTH-R mRNA abundance in normoxic and LTH FACs. We also determined
the effects of altered NO exposure on cortisol biosynthesis.

Materials and Methods
Animals
Time-dated pregnant ewes were maintained at the Barcroft Laboratory White
Mountain Research Station (3820m, maternal PO2 ~ 60mmHg) from approximately day
40 of gestation to near term (term = 146 days). Following transportation to the laboratory,
hypoxia was maintained by nitrogen infusion through a maternal tracheal catheter as
previously described (1, 15, 28, 41, 50, 68). Age-matched, normoxic ewes served as
controls. On days 138-142 of gestation, ewes were sedated and maintained under general
anesthesia while fetuses were delivered through midline laparotomy. Procedures were
performed as previously described in detail (40). Fetal adrenal glands were collected in
ice-cold media DMEM (Sigma-Aldrich, St. Louis, MO), containing 3.2 g sodium
bicarbonate for cell dispersion and subsequent study. All procedures were conducted with
the approval of the Institutional Animal Care and Use Committees (Loma Linda
University School of Medicine, Loma Linda, CA).

Cell Dispersion
Fetal adrenal glands were divided in half along the longitudinal axis and the
cortex was separated from the medulla. The cortical tissue was minced and enzymatically
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dispersed with 40 mg collagenase Type II (Worthington Biomedical, Lakewood, NJ), 40
mg of Polypep bovine protein digest (Sigma-Aldrich) and 100 µl of DNAse I (Type IV)
(Sigma-Aldrich) dissolved in 10 ml of Sodium Krebs Buffer (0.4% collagenase). The
resulting mono-dispersed FACs were aliquoted 2.5x105 cells/mL into 24 well plates with
media (DMEM-FBS 5%), and incubated for 24h at 37°C and 5% CO2 prior to initiation
of the study as required by the experimental protocol. FBS was added to DMEM cell
media to provide the necessary factors require for cell growth. Cell viability was
confirmed by Trypan blue exclusion. All procedures were performed as previously
described and validated for our laboratory (50, 69).

Treatment Protocol
Effects of NOS Inhibition, NO Supplementation, and ACTH Stimulation on Cortisol
Biosynthesis and CYP11A1, CYP17, StAR, and ACTH-R mRNA Abundance
To examine the effects of NO on mRNA abundance and cortisol production, we
used the NO donor (Z)-1-[2-(2-aminoethyl-N-(2-ammonioethyl)amino]diazen-1-ium-1,2diolate (DETA-NO) (26), and NOS inhibitor N(G)-nitro-L-arginine methyl ester (LNAME). Continuous exposure to NO donors is potentially cytotoxic, therefore DETANO was chosen for this experiment because we have previously shown that this NO
donor does not affect cell viability during cell culture (24). It also has a long half-life and
the chosen dose (20uM) maintains physiological levels of NO (4, 7, 53). The dose of LNAME used was that found to be effective in a previous study (41).
After the 24h incubation, all media was removed from each well, labeled 0h post
treatment, and immediately frozen in liquid nitrogen and stored at -80C until
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determination of cortisol. Following the initial media collection, FACs were either
untreated, treated with NOS inhibitor L-NAME (1 mM), treated with NO donor DETANO (20 µM), or treated with stress levels of ACTH (100 pM), with and without L-NAME
or DETA-NO in DMEM-FBS, and returned to the incubator at 37°C and 5% CO2. Media,
along with the appropriate agonist or antagonist were replaced every 24 h for a total of 96
h post treatment and collected media was immediately frozen in liquid nitrogen, and
stored at -80°C until determination of cortisol. At the end of the 96h treatment period,
cells were lysed in 250 µL Denaturation Solution (Ambion) per well for 20 min, rinsed
with 200 µL Denaturation Solution, frozen in liquid nitrogen, and stored at -80C until
analysis.

Cortisol Assay
Cortisol was measured using a commercially available enzyme-linked
immunosorbent assay (ELISA) cortisol kit (Oxford Biomedical Research, Oxford, MI)
that has been previously described and validated for use in our laboratory (16, 41, 46).

qRT-PCR
Quantitative real-time PCR analysis. Quantitative real-time (qRT) PCR was used
to quantify the mRNA for CYP17, CYP11A1, StAR, and ACTH-R (MC2). Total RNA
was prepared from adrenal cortical cells (n=5 for normoxic and LTH) with an RNA
preparation kit as per the manufacturer’s instructions (Qiagen). Before qRT-PCR, total
RNA (1 µg) was treated with DNase I (1 U) at 37°C for 60 min and DNase was removed
via PCR purification columns. Reverse transcription was performed using 1 µg of total
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RNA per sample, oligo (dT21) as the primer, and Superscript II (Invitrogen) as reverse
transcriptase. The details of the qRT PCR have been previously described for our
laboratory in detail (45, 49). For all genes of interest, real-time PCR was also performed
using control reverse-transcription reactions in which the reverse transcriptase was
purposely omitted.
Real-time PCR was performed using cDNA generated from the first-strand
synthesis reaction. All PCRs were performed in triplicate. For CYP11A1, CYP17,
ACTH-R, and cyclophilin, 50 ng cDNA/PCR reaction were used. For the qRT-PCR, Sybr
green (1x Sybr green master mix; Quanta Biosciences, Gaithersburg, Maryland) was
utilized as the fluorophore, and real-time PCR was performed utilizing a Bio-Rad iCycler
equipped with the real-time optical fluorescent detection system. The primer sequences
used are listed in Table 1; the primers were derived from cDNA sequences available at
the National Center for Biotechnology Information (ovine CYP17: AF251388; ovine
CYP11A1: D50057; ovine StAR: AF290202; ovine ACTH receptor: NM_001009442;
bovine cyclophilin B: BT020966). A three- step PCR was used: an initial denaturation
step of 95°C for 1.5 min to activate the hot-start Taq DNA polymerase, followed by
sequential cycles consisting of denaturation at 95°C for 45 s, annealing at 55°C for 30 s,
and extension at 72°C for 45 s. A total of 35 PCR cycles were performed. qRT-PCR was
performed for each sample (in triplicate) for cyclophilin as a control mRNA using the
identical first-strand cDNA used for quantification of mRNA for the gene of interest and
in the same PCR run as for the gene of interest to circumvent any between-run variation.
Cyclophilin was used as a “housekeeping” mRNA, since we previously found that
cyclophilin mRNA is not glucocorticoid responsive and does not change in expression in
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adrenal cells in vitro in response to a variety of stimuli, including ACTH. For
quantification purposes, a synthetic, double-stranded DNA standard was used to generate
a standard curve for extrapolation of starting cDNA concentrations per reaction using the
Ct (threshold at which the fluorescence of each PCR reaction increased above baseline)
values for standards to create a linear standard curve (100, 10, 1, 0.1, 0.01, and 0.001 pg
of standard cDNA). Extrapolation of unknowns from the standard curve was performed
using Prism 3 (GraphPad Software, San Diego, CA), predicting unknowns from the
standard curve Ct values.
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Table 1. Forward and reverse primer sequences used for quantitative real-time PCR
Gene
Primer Sequence
NCBI
CYP17

CYP11A1

StAR

ACTH-R

CYCLO

Fw

5'-CATCAGAGAAGTGCTCCGAATCC-3'

Rv

5'-TCCTGCTCCAAAGGGCAAGTAG-3'

Fw

5'- GGAGGATGTCAAGGCCAATA-3'

Rv

5'- TCTTGCTTATGTCGCCCTCT-3'

Fw

5'-CAGAAGATTGGAAAAGACACGGTC-3'

Rv

5'-AGGTGAGTTTGGTCCTTGAGGG-3'

Fw

5'-ATGAAACACATTCTCAATCTG-3'

Rv

5'-AACGTTTTCCAAAATCTTGTAC-3'

Fw

5'-CCATCGTGTGATCAAGGACTTCAT-3'

Rv

5'-CTTGCCATCTAGCCAGGCAGTCTT-3'

AF251388

D50057

AF290202

NM_001009442

BT020966

Fw, forward; Rv, reverse; CYCLO, cyclophilin; CYP17, 17a-hydroxylase; CYP11A1,
cholesterol side-chain cleavage; StAR, steroidogenic acute regulatory protein; ACTH-R,
adrenocorticotropic hormone receptor; NCBI, National Center for Biotechnology
Information.
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Statistical Analysis
Descriptive statistics are presented as mean ± standard error. Data analysis for
cortisol was performed using two-way analysis of variance (ANOVA) with 1 betweensubject factor (treatment) and 1 within-subject factor (time) stratified by oxygenation
level (normoxic or LTH). Cortisol levels are reported as log transformed due to the large
scale of change between control untreated and ACTH treatment. Data analysis for mRNA
abundance was performed using two-way ANOVA with 1 between-subject factor
(oxygenation level) and 1 within-subject factor (treatment). Alpha was set at .05
significance level. Post hoc tests were adjusted using the Bonferroni method. Statistical
analyses were performed GraphPad Prism 5 (Version 5.04; GraphPad Software, Inc.,
2010).

Results
Effects of NO on Cortisol Production
There were no differences observed in cortisol production from either normoxic
(n=5) or LTH (n=5) FACs that were treated with DETA-NO or L-NAME compared to
untreated cells, and cortisol levels remained relatively constant throughout the 96h time
course (Figure 1). In normoxic FACs, ACTH treatment significantly increased cortisol
output by 24h and remained significantly elevated throughout the 96h time course
compared to untreated FACs. In LTH FACs, ACTH treatment significantly increased
cortisol output by 48h but production fell off by 96h. DETA-NO and L-NAME treatment
did not significantly affect ACTH-stimulated cortisol for the entire course of treatment in
either normoxic or LTH FACs. Although not significant, there was a trend for cortisol
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production from normoxic FACs to be higher than LTH FACs in response to ACTH
(838.64 +/- 359.57 Normoxic vs 573.39 +/- 310.11 LTH ACTH only; 834.30 +/- 385.94
Normoxic vs 260.99 +/- 74.60 LTH ACTH + L-NAME; 1000.62 +/- 444.35 Normoxic vs
430.08 +/- 131.92 LTH ACTH + DETA-NO).

Effects of NO on mRNA Abundance of CYP11A1, CYP17, StAR, and ACTH-R
DETA-NO and L-NAME had no significant effects on mRNA abundance of
CYP11A1, CYP17, StAR, and ACTH-R in both normoxic and LTH FACs (Figures 2-5).
ACTH treatment increased expression in both normoxic and LTH FACs. There were no
significant changes in basal mRNA abundance between normoxic and LTH FACs.
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Figure 1. Time course of cortisol production in normoxic and LTH FACs with NO donor
DETA-NO and NOS inhibitor L-NAME treatment, with and without ACTH stimulation.
Treatment with ACTH (100pM) increased cortisol production in both normoxic and LTH
FACs. DETA-NO (20µM) and L-NAME (1mM) had no effect on cortisol, in the presence
and absence of ACTH in both normoxic and LTH. (Normoxic n=5, LTH n=5) Values
represent mean values ± SEM. *p<0.05 compared to time control. FACs, fetal
adrenocortical cells; LTH, long-term hypoxia; DETA-NO, (Z)-1-[2-(2-aminoethyl-N-(2ammonioethyl)amino]diazen-1-ium-1,2-diolate; L-NAME, N(G)-nitro-L-arginine methyl
ester; ACTH, adrenocorticotropic hormone.
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Figure 2. mRNA abundance of CYP11A1 in normoxic and LTH FACs in response to NO
donor DETA-NO and NOS inhibitor L-NAME treatment, with and without ACTH
stimulation. Treatment with ACTH (100pM) increased mRNA in both normoxic and LTH
FACs compared to control. DETA-NO (20µM) and L-NAME (1mM) had no effect on
mRNA, in the presence and absence of ACTH in both normoxic and LTH. (Normoxic n=5,
LTH n=5) Values represent mean values ± SEM. FACs, fetal adrenocortical cells; LTH,
long-term
hypoxia;
DETA-NO,
(Z)-1-[2-(2-aminoethyl-N-(2ammonioethyl)amino]diazen-1-ium-1,2-diolate; L-NAME, N(G)-nitro-L-arginine methyl
ester; ACTH, adrenocorticotropic hormone.
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Figure 3. mRNA abundance of CYP17 in normoxic and LTH FACs in response to NO
donor DETA-NO and NOS inhibitor L-NAME treatment, with and without ACTH
stimulation. Treatment with ACTH (100pM) increased mRNA in both normoxic and LTH
FACs compared to control. DETA-NO (20µM) and L-NAME (1mM) had no effect on
mRNA, in the presence and absence of ACTH in both normoxic and LTH. (Normoxic n=5,
LTH n=5) Values represent mean values ± SEM. FACs, fetal adrenocortical cells; LTH,
long-term
hypoxia;
DETA-NO,
(Z)-1-[2-(2-aminoethyl-N-(2ammonioethyl)amino]diazen-1-ium-1,2-diolate; L-NAME, N(G)-nitro-L-arginine methyl
ester; ACTH, adrenocorticotropic hormone.
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Figure 4. mRNA abundance of StAR in normoxic and LTH FACs in response to NO donor
DETA-NO and NOS inhibitor L-NAME treatment, with and without ACTH stimulation.
Treatment with ACTH (100pM) increased mRNA in both normoxic and LTH FACs
compared to control. DETA-NO (20µM) and L-NAME (1mM) had no effect on mRNA,
in the presence and absence of ACTH in both normoxic and LTH. (Normoxic n=5, LTH
n=5) Values represent mean values ± SEM. FACs, fetal adrenocortical cells; LTH, longterm hypoxia; DETA-NO, (Z)-1-[2-(2-aminoethyl-N-(2-ammonioethyl)amino]diazen-1ium-1,2-diolate;
L-NAME,
N(G)-nitro-L-arginine
methyl
ester;
ACTH,
adrenocorticotropic hormone.
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Figure 5. mRNA abundance of ACTH-R in normoxic and LTH FACs in response to NO
donor DETA-NO and NOS inhibitor L-NAME treatment, with and without ACTH
stimulation. Treatment with ACTH (100pM) increased mRNA in both normoxic and LTH
FACs compared to control. DETA-NO (20µM) and L-NAME (1mM) had no effect on
mRNA, in the presence and absence of ACTH in both normoxic and LTH. (Normoxic n=5,
LTH n=5) Values represent mean values ± SEM. FACs, fetal adrenocortical cells; LTH,
long-term
hypoxia;
DETA-NO,
(Z)-1-[2-(2-aminoethyl-N-(2ammonioethyl)amino]diazen-1-ium-1,2-diolate; L-NAME, N(G)-nitro-L-arginine methyl
ester; ACTH, adrenocorticotropic hormone.

126

Discussion
In response to conditions of long-term moderate gestational hypoxia (LTH), the
fetus has the ability to adapt the hypothalamic-pituitary-adrenal (HPA) axis to preserve
normal growth and development. Under basal conditions, normal basal plasma cortisol
concentrations are maintained, despite elevated levels of adrenocorticotropic hormone
(ACTH) (45). However, the LTH fetus has a heightened cortisol response to acute
secondary stressors compared to normoxic fetuses (1, 28). There is also reduced
expression of key steroidogenic enzymes CYP11A1 (P450 side chain cleavage) and
CYP17 (P450 17α-hydroxylase), as well as reduced ACTH receptor (ACTH-R) mRNA
in the LTH adrenal cortex (46), but expression of steroidogenic acute regulatory (StAR)
protein is greater in LTH compared to normoxic fetal adrenocortical cells (FACs) (68).
Together these changes suggest an adaptive response to LTH to prevent excessive
cortisol production that would restrict fetal growth, but allow for enhanced cortisol
production in response to a secondary stress.
A possible effector on cortisol production in this system is nitric oxide (NO).
Aside from its well established role in the vascular system, NO has also been shown to
inhibit steroidogenesis in a variety of tissues. NO reduced steroidogenesis in ovarian
tissue of women (67), pigs (34, 35), rabbits (19, 73), and rats (39), and NO also reduced
testosterone (30) and cortisol secretion (2) in the adult rat. Inhibition of NOS increased
testosterone in the Leydig cells (14) and increased aldosterone production in humans
(43). In the adrenal, NO inhibited basal, ACTH, and angiotensin II-induced aldosterone
production in zona glomerulosa cells of adult rat adrenal cortex transfected with eNOS
(21, 22) and adult bovine zona glomerulosa cells (23). In rat zona fasciculata cells, NO
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donors decreased both unstimulated and ACTH-stimulated corticosterone production, and
NOS inhibition enhanced glucocorticoid output (11, 12). In our lab, we have shown that
NO inhibits cortisol biosynthesis and that inhibition of NOS enhances cortisol output in
ovine LTH FACs (41), therefore nitric oxide may play an important role in the fetal
adaptation to LTH in regulating cortisol production.
This study investigated the effects of NO on cortisol production and mRNA
abundance of key steroidogenic enzymes CYP11A1 and CYP17, as well as StAR and
ACTH-R in ovine FACs to determine a potential point of action of NO. Cortisol
biosynthesis in the adrenal is initiated by ACTH activation of ACTH-R (38). Subsequent
signaling leads to StAR-mediated translocation of cholesterol from the outer to the inner
mitochondrial membrane, providing substrate, where CYP11A1 converts cholesterol into
pregnenolone (3, 9, 52, 55, 56). CYP17 continues cortisol biosynthesis by mediating the
17α-hydroxylation of pregnenolone to 17α-hydroxypregnenolone and progesterone to
17α-hydroxyprogesterone (25). Changes in these proteins would directly affect the ability
of the fetus to produce cortisol.
Interestingly we found that treatment with either the NO donor DETA-NO or
NOS inhibition with L-NAME over 96h did not affect cortisol production compared to
untreated cells in both normoxic and LTH FACs, however ACTH stimulation
significantly increased cortisol output in normoxic FACs by 24h and in LTH FACs by
48h compared to untreated cells (Figure 1). ACTH-stimulated cortisol biosynthesis was
not significantly affected by either DETA-NO or L-NAME treatment in both normoxic
and LTH FACs, however this could be due to sustained stimulation of the cells with
stress levels of ACTH. ACTH has been shown to increase the expression of CYP11A1
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and CYP17 in the fetal adrenal (10, 18, 47, 48, 54, 57, 63), and elevated ACTH in the
fetal sheep was shown to be accompanied by increased 30 kDa StAR (72), the inactive
spent form, suggesting enhanced translocation of cholesterol to the inner mitochondrial
membrane. Together, the increased levels of ACTH through continuous treatments in this
study would result in increased levels of these enzymes followed by increased production
of cortisol. These increases in gene expression could overcome NO inhibition to produce
cortisol in response to stress.
We also found that cortisol output from normoxic FACs tended to reach higher
levels than those in LTH FACs in response to ACTH. This could be due to the lack of
cholesterol availability in the media. The production of steroid hormones is dependent on
the availability of cholesterol within the steroidogenic cells. Sources of cholesterol
include from the serum high density lipoproteins (HDLs) or low density lipoprotein
(LDL) (20, 31), or de novo synthesis from acetate. Steroidogenesis occurs when
cholesterol is mobilized from cellular stores to the outer mitochondrial membrane, via
cholesterol esterase (5, 6, 64), or taken up from the plasma, followed by the transfer from
the outer to the inner mitochondrial membrane by StAR (29, 33, 62). We have recently
shown that LDL receptor and HMG-CoA Reductase mRNA was increased in whole
adrenal cortex in the LTH fetus compared to normoxic control (unpublished results),
however basal and ACTH stimulated cortisol output was lower in LTH compared to
control in FACs over the course of 36h (70). This suggests that although LTH adrenals
seem to have increased capacity for LDL uptake and de novo synthesis of cholesterol
from acetate, there may be a defect in LDL transport in the LTH fetal adrenal cortex
compared to normoxic controls.
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Our earlier acute studies indicated a significant inhibitory effect of NO on cortisol
biosynthesis in the LTH FACs (41). With this in mind, we wanted to determine if NO had
a potentially longer lasting effect and altered gene expression of key proteins involved in
cortisol production. In the present study we found that treatment with DETA-NO or LNAME both with or without ACTH for 96h had no significant effect on mRNA
abundance of CYP11A1, CYP17, StAR, and ACTH-R in both normoxic and LTH FACs
(Figure 2). ACTH treatment, however, increased mRNA in both normoxic and LTH
FACs, but unlike our previous study (46), levels in untreated cells were not different in
LTH compared to normoxic. This could be due to a lack of basal ACTH stimulation; as
we have previously shown, ACTH is required for normal CYP11A1 and CYP17
expression (47, 48). Together these results suggest that NO does not play a significant
role in the regulation of CYP11A1, CYP17, StAR, and ACTH-R mRNA, and that
changes in mRNA are not responsible for the inhibition of acute ACTH-induced cortisol
production by NO that we have previously observed (41).
The effects of NO on steroidogenesis, including cortisol production, have been
well established, but the mechanism of action is still uncertain. In this study we showed
that NO does not affect mRNA abundance of key steroidogenic enzymes and proteins,
but NO may alter steroidogenesis by other post-translational mechanisms. One possibility
is that NO may act directly on the CYP enzymes, through competitive interaction at the
heme-oxygen binding site of CYP11A1 and CYP17 (22), or indirectly through Snitrosylation of CYP11A1 and CYP17 (60). It has been shown that NO is capable of
interacting with the heme-oxygen binding site of CYP11A1 and CYP17 (65, 66), and
because these enzymes use several rounds of attack of the heme-oxygen complex on the
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steroid substrate (51), they may be more sensitive to NO inhibition than other enzymes. It
has also been demonstrated that decreased oxygen concentrations resulted in a lower
threshold for NO-mediated inhibition of aldosterone synthesis in adult rat adrenals (21),
suggesting that the LTH fetus may be more susceptible to NO inhibition of cortisol.
NO may also act through S-nitrosylation of key Cys residues in the active sites on
CYP11A1 and CYP17, which could lead to suppressed steroidogenic activity and
decreased cortisol production. S-nitrosylation has been unexplored in steroidogenic CYPs
but it has been shown in the liver to affect both CYP transcription through zinc finger
transcription interaction (71), as well as reduction in CYP expression (32). Snitrosylation has also been proposed as the mechanisms responsible for the NO-induced
inhibition of aromatase activity in granulosa cells (58), and inhibition of corticosterone
production in rat adrenocortical cells (12). These interactions of NO on CYP11A1 and
CYP17 activity may lead to inhibition of acute ACTH-induced steroidogenesis following
NO treatment in LTH FACs.
The HPA axis of the fetal sheep undergoes significant adaptations in response to
development under conditions of LTH. These changes include increased circulating basal
ACTH, but reduced expression of CYP11A1, CYP17, and ACTH-R and normal plasma
cortisol concentrations. Together, these adaptations suggest heightened activation of the
hypothalamic-pituitary arm of the HPA axis, but reduced adrenocortical capacity to
respond to ACTH. This divergent adaptation may serve to limit cortisol production in the
basal state yet allow increased production of cortisol when needed during acute
secondary stress. The mechanisms involved in this adaptation are not yet fully
understood, however nitric oxide appears to still play a role. Although NO has been
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shown to inhibit ACTH-induced cortisol production, the results from this study show that
NO does not affect mRNA abundance of key steroidogenic enzymes CYP11A1 and
CYP17, as well as StAR and ACTH-R. The lack of change in mRNA suggests that the
effects of NO on cortisol biosynthesis are downstream from transcription, perhaps
affecting enzyme activity through competition at the heme-oxygen binding site or
through S-nitrosylation in the activation sites of the CYP enzymes. Future work should
investigate the possibility of S-nitrosylation of the CYP enzymes as a mechanism for
NO-induced cortisol inhibition.
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CHAPTER SIX
CONCLUSIONS

Hypoxia is a common fetal stress that can occur during pregnancy due to maternal
malnutrition, smoking, heart or lung disease, obesity, preeclampsia, or exposure to high
altitude (3, 19, 27, 38, 47, 69). The fetus synthesizes cortisol from the fetal adrenal as part
of the hypothalamus-pituitary-adrenal axis (HPA) response to stress (1, 6, 7, 45, 46).
Regulation of cortisol is important for normal fetal development due to its involvement in
growth and organ maturation, as well as regulation of plasma glucose, lipid, and protein
concentrations (10, 56, 66). Through studies in our lab, we have shown that the fetus has
the ability to adapt to chronic stress during the course of gestation. When exposed to
moderate gestational hypoxia during the last hundred days of gestation (long-term
hypoxia, LTH), basal levels of cortisol remain similar to levels in the normoxic fetus,
despite elevated levels of ACTH (67), and when challenged with a secondary stressor, the
LTH fetus responds with a higher output of cortisol than the normoxic fetus (1, 45). We
also found that expression of two key steroidogenic P450 enzymes, CYP11A1 and
CYYP17, was decreased along with the ACTH receptor (ACTH-R) in LTH FACs (68),
and that StAR expression was increased (82). Together, these changes suggest an
adaptation in the fetal adrenal that maintains normal basal levels of cortisol required for
fetal development, but allows for enhanced cortisol in response to a secondary stress.
These adaptations may be mediated through NO produced by eNOS in the adrenocortical
cells.
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The effects of nitric oxide have been well established in adult steroidogenic
tissues and cells, with increases in NO leading to reduced steroidogenesis (21, 26, 36, 3941, 51, 54, 55, 61, 81, 85) and inhibition of NOS resulting in increased steroid production
(20, 26, 65). This key role of NO has been demonstrated in a variety of species, including
human and rat, however there are very few studies on the effects of NO in the fetus, as
well as limited studies on the regulation of NOS in non-endothelial cells. In our lab, we
have studied the effects of NO on ovine fetal adrenal cortical cells (FACs) as well as the
effects of exposure to LTH. We found that NO inhibits cortisol biosynthesis, while
inhibition of NOS enhances cortisol output in ovine LTH FACs (64). We have also
shown that eNOS expression is upregulated in LTH FACs (63), suggesting that NO via
eNOS may play a role in the fetal adaptation to LTH.
Regulation of eNOS can occur through multiple post-translational mechanisms
including phosphorylation via MEK/ERK1/2 and PI3K/Akt signaling, as well as
calcium/calmodulin (4, 5, 12-14, 28). Changes in phosphorylation of eNOS at serine
activation site 1177 in human, 1179 in bovine/ovine (25, 33, 34), could lead to altered
NOS activity and subsequent NO production that could ultimately have an effect on
cortisol biosynthesis. This brought us to our general hypothesis that adaptations in
cortisol production in the LTH fetus are mediated by eNOS-derived NO. Specifically, we
investigated the role of key signaling pathways MEK/ERK1/2, PI3K/Akt, and calcium in
regulating eNOS phosphorylation (peNOS) at Ser1177/79 and the subsequent effects of
changes in these pathways on cortisol production in ovine LTH FACs. We also
determined the effects of NO on the expression of key steroidogenic enzymes CYP11A1
and CYP17, as well as steroidogenic proteins StAR and ACTH-R and the potential
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effects on cortisol biosynthesis. Through studying the role of these key signaling
pathways on peNOS and the impact of NO on the CYPs, StAR, and ACTH-R along with
their effects on cortisol biosynthesis in FACs, we wanted to better understand the
influence of LTH in the ovine fetus and adaptations that may occur in the fetal adrenal
response to LTH as a chronic stressor during pregnancy.
A variety of studies have shown that inhibition of the MEK/ERK1/2 pathway with
UO126 (UO) reduces peNOS and NO production (11, 52, 60, 62), and a previous study
from our lab showed that MEK/ERK1/2 inhibition with UO resulted in decreased ACTHstimulated cortisol output in FACs (83). In chapter 2, we determined that the
MEK/ERK1/2 signaling pathway is involved in the adaptive increase in ACTHstimulated cortisol in LTH FACs, however this effect is not mediated through peNOS;
UO treatment did not reduce peNOS. Instead, it is likely that MEK/ERK1/2 signaling is
more important for cholesterol transport in the mitochondria as inhibition of this pathway
with UO prevented the increase in cortisol observed in response to ACTH treatment, but
had no effect on ACTH-stimulated cortisol levels in the presence of membrane permeable
22R-hydroxycholesterol (22R-OHC). These findings are consistent with other studies that
have shown that UO blocks steroidogenesis in both granulosa (24) and Leydig cells (53,
71) but does not affect steroid production in cells treated with 22R-OHC.
Another signaling pathway that has been shown to target eNOS at Ser1177/79 in
endothelial cells (33, 42, 60) is the PI3K/Akt pathway. In our FACs we found that, unlike
the MEK/ERK1/2 pathway, the PI3K/Akt pathway played a significant role in regulating
peNOS as well as cortisol production in LTH FACs. In response to PI3K/Akt pathway
inhibition with wortmannin, ACTH-stimulated cortisol was elevated above levels
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produced by ACTH stimulation alone, and peNOS was reduced compared to untreated
cells. Together this suggests that peNOS is closely linked to cortisol biosynthesis in the
LTH fetus, and that the PI3K/Akt pathway works in the LTH fetus to prevent even higher
levels of cortisol under stimulating conditions.
In both these experiments we demonstrated divergent effects of ACTH on cortisol
and peNOS in the LTH FACs; treatment with ACTH increased cortisol while decreasing
peNOS, supporting our hypothesis that eNOS is involved in the fetal adaptation to LTH.
When combined with higher levels of eNOS protein in LTH adrenals that we previously
observed (63) and the ability of NO to inhibit cortisol production in LTH FACs (64), the
PI3K/Akt pathway and ACTH may work together in LTH FACs to regulate peNOS;
PI3K/Akt signaling maintains peNOS and NO production while ACTH stimulation
overrides PI3K/Akt signaling to reduce peNOS and limit NO. This mechanism would
preserve normal basal cortisol levels but allow for a robust cortisol response in stressed
FACs in LTH compared to normoxic controls.
In a concurrent study with chapter 2, chapter 3 assessed the role cAMP activation
of steroidogenesis via membrane permeable analog 8Bromo-cAMP (8Br). ACTHstimulation of cortisol classically occurs through 3,5-cAMP/PKA activation of StAR
protein (23, 76), and 8Br has been shown to effectively increase glucocorticoids in
adrenal cells (17, 20, 21), supporting cAMP/PKA regulation. Because 8Br is membrane
permeable, it bypasses ACTH-activation of the ACTH-R and stimulates PKA directly to
determine if the fetal adaptation to LTH is cAMP-dependent. Consistent with previous
studies using ACTH, 8Br treatment enhanced cortisol production in LTH FACs above
levels observed in normoxic controls. We also found that MEK/ERK1/2 pathway
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inhibition with UO reduced 8Br-stimulated cortisol output, further supporting the
involvement of the MEK/ERK1/2 pathway in cortisol production and indicating that UO
inhibition of cortisol synthesis is downstream of cAMP/PKA signaling. However, 8Br
treatment had no effect on peNOS, suggesting that the use of this analog was not able to
replicate the actions of endogenous cAMP, or that ACTH-mediated dephosphorylation of
eNOS is not cAMP dependent and that alternative signaling mechanisms are activated to
induce phosphatase activity in LTH FACs.
A possible intermediary between ACTH and eNOS is protein phosphatase 2A
(PP2A). PP2A has been shown to be capable of dephosphorylating eNOS and the
inhibition of PP2A with okadaic acid increases peNOS in endothelial cells (37, 57),
however the effects of LTH on this system are unexplored. Preliminary data from our lab
shows significantly greater PP2A expression in the LTH adrenal cortex compared to
normoxic tissue (unpublished results) suggesting the involvement of PP2A in the fetal
adaptation to LTH. If ACTH increases PP2A activity, combined with greater PP2A
expression, it would reduce peNOS, thereby reducing NO production and effectively
limiting the inhibition of NO on cortisol production in LTH FACs. Further studies
examining the activity of PP2A in the fetal adrenal cortex could help determine the
mechanism responsible for ACTH-mediated reduction in peNOS.
Calcium regulation of eNOS activity has been well characterized in endothelial
cells; increases in intracellular calcium using calcium ionophore A23187 increased
peNOS and NO production (8, 43, 84), and calcium chelators and calcium free media
prevented stimulated increases in peNOS (31, 35). The effects of calcium on
steroidogenic cells have not yet been explored, and the impact of hypoxia on calcium
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regulation of eNOS is uncertain. Chapter 4 investigated the effects of increasing
intracellular calcium in FACs and we found that peNOS and cortisol were unaffected;
both basal and ACTH-stimulated levels of peNOS and cortisol did not change in response
to elevated calcium. This suggests that calcium does not play a major role in regulating
fetal adrenal eNOS and is not involved in the fetal adaptation to LTH. The lack of
involvement of calcium in the regulation of eNOS may be due to tissue specificity (30),
or the requirement of calcium may be reduced due to the type of agonist in FACs (9, 80).
Cortisol biosynthesis in the adrenal requires a series of enzymatic steps initiated
by ACTH signaling through the ACTH receptor (ACTH-R) to activate steroidogenic
acute regulatory (StAR) protein (59). Following activation, StAR transports cholesterol to
the inner mitochondrial membrane where the key rate-limiting enzyme cytochrome P450
side-chain cleavage (CYP11A1) cleaves cholesterol into pregnenolone (2, 16, 58, 59, 70,
78). Cytochrome P450 17α-hydroxylase (CYP17) then continues cortisol biosynthesis by
mediating the 17α-hydroxylation of pregnenolone to 17α-hydroxypregnenolone and
progesterone 17α-hydroxyprogesterone (44). In adrenal cells, NO has been shown to
inhibit CYP expression (29, 77) and activity (20, 22, 41), which would limit cortisol
production, and previous studies from our lab found that NO inhibited ACTH-stimulated
cortisol while NOS inhibition enhanced cortisol output in LTH FACs (64). For chapter 5,
we sought to determine a potential point of action for NO and any longer lasting effects
in gene expression. We found that extended NO exposure, via NO donor DETA-NO, or
removal, via NOS inhibitor L-NAME, had no effect on mRNA abundance of key
steroidogenic enzymes CY11A1 and CYP17, and key steroidogenic proteins StAR and
ACTH-R. In contrast to our acute studies (64), there were also no significant changes in
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ACTH-induced cortisol production in response to NO exposure or removal. This suggests
that the effects of NO are downstream from transcription and may inhibit cortisol
biosynthesis through competition at the heme-oxygen binding site or through Snitrosylation in the CYP enzyme activation sites. We have recently found that NO
induces S-nitrosylation of CYP11A1 in LTH FACs (unpublished results). Although these
data are from a limited number of animals, the continuation of this work will be
important in determining the mechanism of action for NO in inhibiting cortisol
production as a part of the fetal adrenal adaptation to LTH.
Taken together, these studies address the potential adaptations in the role of NO
and the regulation of its production via peNOS in response to LTH in the ovine fetal
adrenal gland under basal and stressed conditions. In investigating the signaling pathways
involved in regulating peNOS, we found that the PI3K/Akt pathway may work to
maintain basal levels of cortisol through peNOS-derived NO. Stimulation of FACs with
stress levels of ACTH could override this signal, possibly through activation of PP2A, to
reduce peNOS and NO inhibition, allowing for the enhanced levels of cortisol produced
in LTH FACs. Future studies could investigate the activity of PP2A through use of
specific inhibitors or activators to see if changes in PP2A activity affect peNOS and
subsequent cortisol production. This would further elucidate the adaptations in signaling
mechanisms involved in regulating peNOS in the LTH fetal adrenal, and if there are any
differential effects in LTH compared to normoxic. Although NO does not seem to have
any effects on gene expression of key steroidogenic proteins, the inhibitory abilities of
NO could be through direct actions on the proteins via S-nitrosylation or competition
with O2 for the heme-oxygen binding site. Continuation of our current studies on the
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effects of NO on S-nitrosylation of CYP11A1 could provide further insight into the
adaptive mechanisms responsible for the changes observed in cortisol production in the
LTH fetus.
Many fetal and maternal conditions including maternal malnutrition, smoking,
heart or lung disease, obesity, preeclampsia, or exposure to high altitude (3, 19, 27, 38,
47, 69) can result in varying degrees of hypoxia that can adversely affect the developing
fetus and increase perinatal morbidity and mortality. In response to hypoxic stress, the
fetus synthesizes cortisol from the fetal adrenal as part of the hypothalamus-pituitaryadrenal axis (HPA) (1, 6, 7, 45, 46). Due to its involvement in growth and organ
maturation, as well as its effects on metabolism, regulation of cortisol is important for
normal fetal development (10, 56, 66).When exposed to hypoxic conditions for an
extended period of time, the fetus can adapt in order to preserve normal growth and
development. We have shown that basal levels of cortisol remain similar to levels in the
normoxic fetus, despite elevated levels of ACTH (67), and when challenged with a
secondary stressor, the LTH fetus responds with a higher output of cortisol than the
normoxic fetus (1, 45). We suspect this ability of the fetus is due to NO produced by
eNOS and that the regulation of eNOS activity is altered in response to LTH.
Because NO has such potent effects on steroidogenesis and involvement in the
fetal adaptation to LTH, its therapeutic use should be considered carefully. Currently,
inhaled NO (iNO) is used clinically as a treatment in the neonatal intensive care unit
(NICU) for premature infants with respiratory distress syndrome (75) and newborns with
persistent pulmonary hypertension (18, 48, 50) to induce selective pulmonary
vasodilation (32) and reduce the incidence of chronic lung disease and death. In the
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newborn lamb, it has been reported that iNO reversed hypoxic pulmonary
vasoconstriction (72), and increased oxygenation (86) and survival (87), and in the
human, iNO rapidly increased oxygenation in infants with severe hypoxemia and
pulmonary-artery hypertension, without causing systemic hypotension (50, 73). Although
iNO is rapidly metabolized in the lung (49), limiting the direct effects of NO on the
adrenal, the potential systemic effects through increases in oxygen could influence
steroidogenesis and alter cortisol production in the LTH adapted newborn. If the newborn
has adapted the HPA as a fetus to lower levels of oxygen in response to LTH, suddenly
increases in systemic oxygen through the use of iNO could have negative consequences
by superseding NO regulation of cortisol in the adrenal and increasing cortisol output. If
high levels of cortisol are sustained, they could interfere with the HPA response to acute
stressors associated with extrauterine life and be detrimental to the newborn’s growth and
development, as elevated cortisol is associated with hyperglycemia, immune suppression,
excess adipose deposition, bone loss, and hypertension (15, 74, 79). Understanding the
mechanisms of action for the regulation of NO and cortisol production are important for
determining the adaptations in the fetal HPA in response to LTH, and they can provide
insight into better care for at risk pregnancies. Determining the long-term effects of
reduced oxygen can also inform on the potential outcomes in the LTH newborn of iNOtreatment induced increases in systemic oxygen currently being used in the NICU.
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